{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:57:23Z","timestamp":1794074243006,"version":"4.8.0"},"reference-count":386,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011019","name":"NKFIH","doi-asserted-by":"crossref","award":["K123975"],"award-info":[{"award-number":["K123975"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011019","name":"NKFIH","doi-asserted-by":"crossref","award":["FK128387"],"award-info":[{"award-number":["FK128387"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Research and Innovation Fund of Hungary","award":["TKP2021-EGA-19"],"award-info":[{"award-number":["TKP2021-EGA-19"]}]},{"name":"National Research and Innovation Fund of Hungary","award":["TKP2021-EGA-20"],"award-info":[{"award-number":["TKP2021-EGA-20"]}]},{"name":"New National Excellence Program of the Ministry for Innovation and Technology","award":["\u00daNKP-21-5-DE-462"],"award-info":[{"award-number":["\u00daNKP-21-5-DE-462"]}],"id":[{"id":"https:\/\/ror.org\/02ey3ab96","id-type":"ROR","asserted-by":"crossref"}]},{"name":"New National Excellence Program of the Ministry for Innovation and Technology","award":["\u00daNKP-21-3-I-DE-105"],"award-info":[{"award-number":["\u00daNKP-21-3-I-DE-105"]}],"id":[{"id":"https:\/\/ror.org\/02ey3ab96","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"crossref","award":["Bolyai fellowship"],"award-info":[{"award-number":["Bolyai fellowship"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Slovenian Research Agency programme","award":["P1-0390"],"award-info":[{"award-number":["P1-0390"]}],"id":[{"id":"https:\/\/ror.org\/059bp8k51","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009232","name":"University of Debrecen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bile acids are soluble derivatives of cholesterol produced in the liver that subsequently undergo bacterial transformation yielding a diverse array of metabolites. The bulk of bile acid synthesis takes place in the liver yielding primary bile acids; however, other tissues have also the capacity to generate bile acids (e.g. ovaries). Hepatic bile acids are then transported to bile and are subsequently released into the intestines. In the large intestine, a fraction of primary bile acids is converted to secondary bile acids by gut bacteria. The majority of the intestinal bile acids undergo reuptake and return to the liver. A small fraction of secondary and primary bile acids remains in the circulation and exert receptor-mediated and pure chemical effects (e.g. acidic bile in oesophageal cancer) on cancer cells. In this review, we assess how changes to bile acid biosynthesis, bile acid flux and local bile acid concentration modulate the behavior of different cancers. Here, we present in-depth the involvement of bile acids in oesophageal, gastric, hepatocellular, pancreatic, colorectal, breast, prostate, ovarian cancer. Previous studies often used bile acids in supraphysiological concentration, sometimes in concentrations 1000 times higher than the highest reported tissue or serum concentrations likely eliciting unspecific effects, a practice that we advocate against in this review. Furthermore, we show that, although bile acids were classically considered as pro-carcinogenic agents (e.g. oesophageal cancer), the dogma that switch, as lower concentrations of bile acids that correspond to their serum or tissue reference concentration possess anticancer activity in a subset of cancers. Differences in the response of cancers to bile acids lie in the differential expression of bile acid receptors between cancers (e.g. FXR vs. TGR5). UDCA, a bile acid that is sold as a generic medication against cholestasis or biliary surge, and its conjugates were identified with almost purely anticancer features suggesting a possibility for drug repurposing. Taken together, bile acids were considered as tumor inducers or tumor promoter molecules; nevertheless, in certain cancers, like breast cancer, bile acids in their reference concentrations may act as tumor suppressors suggesting a Janus-faced nature of bile acids in carcinogenesis.<\/jats:p>","DOI":"10.1007\/s00018-022-04278-2","type":"journal-article","created":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:04:05Z","timestamp":1650099845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":293,"title":["The role of bile acids in carcinogenesis"],"prefix":"10.1007","volume":"79","author":[{"given":"Tadeja","family":"Re\u017een","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damjana","family":"Rozman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcnde","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-445X","authenticated-orcid":false,"given":"Edit","family":"Mik\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"4278_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0168-8278(03)00194-6","volume":"38","author":"B Stieger","year":"2003","unstructured":"Stieger B (2003) Biliary cholesterol secretion: more lessons from plants? J Hepatol 38:843\u2013846","journal-title":"J Hepatol"},{"key":"4278_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1517\/13543776.16.3.333","volume":"16","author":"R Pellicciari","year":"2006","unstructured":"Pellicciari R, Gioiello A, Costantino G (2006) Potential therapeutic applications of farnesoid X receptor (FXR) modulators. Expert Opin Ther Pat 16:333\u2013341","journal-title":"Expert Opin Ther Pat"},{"key":"4278_CR3","doi-asserted-by":"publisher","first-page":"166101","DOI":"10.1016\/j.bbadis.2021.166101","volume":"1867","author":"X Cai","year":"2021","unstructured":"Cai X, Young GM, Xie W (2021) The xenobiotic receptors PXR and CAR in liver physiology, an update. Biochim Biophys Acta Mol Basis Dis 1867:166101","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4278_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s10020-021-00295-2","volume":"27","author":"A Sipos","year":"2021","unstructured":"Sipos A, Ujlaki G, Mik\u00f3 E, Maka E, Szab\u00f3 J, Uray K, Krasznai Z, Bai P (2021) The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med 27:33","journal-title":"Mol Med"},{"key":"4278_CR5","doi-asserted-by":"publisher","first-page":"E1068","DOI":"10.3390\/cancers12051068","volume":"12","author":"B Kiss","year":"2020","unstructured":"Kiss B, Mik\u00f3 E, Seb\u0151 \u00c9, Toth J, Ujlaki G, Szab\u00f3 J, Uray K, Bai P, \u00c1rkosy P (2020) Oncobiosis and microbial metabolite signaling in pancreatic adenocarcinoma. Cancers (Basel) 12:E1068","journal-title":"Cancers (Basel)"},{"key":"4278_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N (2013) Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499:97\u2013101","journal-title":"Nature"},{"key":"4278_CR7","first-page":"958","volume":"2018","author":"E Miko","year":"1859","unstructured":"Miko E, Vida A, Kovacs T, Ujlaki G, Trencsenyi G, Marton J, Sari Z, Kovacs P, Boratko A, Hujber Z, Csonka T, Antal-Szalmas P, Watanabe M, Gombos I, Csoka B, Kiss B, Vigh L, Szabo J, Mehes G, Sebestyen A, Goedert JJ, Bai P (1859) Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness. Biochim Biophys Acta Bioenerg 2018:958\u2013974","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"4278_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.18632\/oncotarget.338","volume":"2","author":"AA Goldberg","year":"2011","unstructured":"Goldberg AA, Beach A, Davies GF, Harkness TA, Leblanc A, Titorenko VI (2011) Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells. Oncotarget 2:761\u2013782","journal-title":"Oncotarget"},{"key":"4278_CR9","doi-asserted-by":"publisher","first-page":"e2445","DOI":"10.7717\/peerj.2445","volume":"4","author":"AA Gafar","year":"2016","unstructured":"Gafar AA, Draz HM, Goldberg AA, Bashandy MA, Bakry S, Khalifa MA, AbuShair W, Titorenko VI, Sanderson JT (2016) Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells. PeerJ 4:e2445","journal-title":"PeerJ"},{"key":"4278_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13402-017-0353-5","volume":"41","author":"TH Luu","year":"2018","unstructured":"Luu TH, Bard JM, Carbonnelle D, Chaillou C, Huvelin JM, Bobin-Dubigeon C, Nazih H (2018) Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells. Cell Oncol 41:13\u201324","journal-title":"Cell Oncol"},{"key":"4278_CR11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3390\/cancers11091255","volume":"11","author":"P Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs P, Csonka T, Kov\u00e1cs T, S\u00e1ri Z, Ujlaki G, Sipos A, Kar\u00e1nyi Z, Sze\u0151cs D, Heged\u0171s C, Uray K, Jank\u00f3 L, Kiss M, Kiss B, Laoui D, Vir\u00e1g L, M\u00e9hes G, Bai P, Mik\u00f3 E (2019) Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer. Cancers (Basel) 11:1255","journal-title":"Cancers (Basel)"},{"key":"4278_CR12","first-page":"146","volume":"2011","author":"T Rezen","year":"1814","unstructured":"Rezen T, Rozman D, Pascussi JM, Monostory K (1814) Interplay between cholesterol and drug metabolism. Biochim Biophys Acta Proteins Proteom 2011:146\u2013160","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"4278_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/138920011795016890","volume":"12","author":"M Hafner","year":"2011","unstructured":"Hafner M, Rezen T, Rozman D (2011) Regulation of hepatic cytochromes p450 by lipids and cholesterol. Curr Drug Metab 12:173\u2013185","journal-title":"Curr Drug Metab"},{"key":"4278_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1194\/jlr.RA119000395","volume":"61","author":"A Honda","year":"2020","unstructured":"Honda A, Miyazaki T, Iwamoto J, Hirayama T, Morishita Y, Monma T, Ueda H, Mizuno S, Sugiyama F, Takahashi S, Ikegami T (2020) Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. J Lipid Res 61:54\u201369","journal-title":"J Lipid Res"},{"key":"4278_CR15","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","volume":"279","author":"G Lorbek","year":"2012","unstructured":"Lorbek G, Lewinska M, Rozman D (2012) Cytochrome P450s in the synthesis of cholesterol and bile acids\u2013from mouse models to human diseases. FEBS J 279:1516\u20131533","journal-title":"FEBS J"},{"key":"4278_CR16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3748\/wjg.15.804","volume":"15","author":"MJ Monte","year":"2009","unstructured":"Monte MJ, Marin JJ, Antelo A, Vazquez-Tato J (2009) Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol 15:804\u2013816","journal-title":"World J Gastroenterol"},{"key":"4278_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","volume":"15","author":"S MahmoudianDehkordi","year":"2019","unstructured":"MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW, John Williams L, Tenenbaum JD, Blach C, Baillie R, Han X, Bhattacharyya S, Toledo JB, Schafferer S, Klein S, Koal T, Risacher SL, Kling MA, Motsinger-Reif A, Rotroff DM, Jack J, Hankemeier T, Bennett DA, De Jager PL, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn CM, Saykin AJ, Kastenmuller G, Kaddurah-Daouk R (2019) Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease-An emerging role for gut microbiome. Alzheimers Dement 15:76\u201392","journal-title":"Alzheimers Dement"},{"issue":"4","key":"4278_CR18","doi-asserted-by":"publisher","first-page":"E293","DOI":"10.3390\/cells8040293","volume":"8","author":"E Miko","year":"2019","unstructured":"Miko E, Kovacs T, Sebo E, Toth J, Csonka T, Ujlaki G, Sipos A, Szabo J, Mehes G, Bai P (2019) Microbiome-microbial metabolome-cancer cell interactions in breast cancer-familiar, but unexplored. Cells 8(4):E293","journal-title":"Cells"},{"key":"4278_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","volume":"70","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Pande A, Schnabl B (2019) Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol 70:260\u2013272","journal-title":"J Hepatol"},{"key":"4278_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, Schoonjans K, Bianco AC, Auwerx J (2006) Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:484\u2013489","journal-title":"Nature"},{"key":"4278_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0166-6622(87)80207-X","volume":"30","author":"AF Hofmann","year":"1987","unstructured":"Hofmann AF, Mysels KJ (1987) Bile salts as biological surfactants. Colloids Surf 30:145\u2013173","journal-title":"Colloids Surf"},{"key":"4278_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.ESP-0001-2018","author":"B Bertani","year":"2018","unstructured":"Bertani B, Ruiz N (2018) Function and biogenesis of lipopolysaccharides. EcoSal Plus. https:\/\/doi.org\/10.1128\/ecosalplus.ESP-0001-2018","journal-title":"EcoSal Plus"},{"key":"4278_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB (2016) Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7:22\u201339","journal-title":"Gut Microbes"},{"key":"4278_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon JM, Kang DJ, Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:241\u2013259","journal-title":"J Lipid Res"},{"key":"4278_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo10110475","volume":"10","author":"J Kuang","year":"2020","unstructured":"Kuang J, Zheng X, Huang F, Wang S, Li M, Zhao M, Sang C, Ge K, Li Y, Li J, Rajani C, Ma X, Zhou S, Zhao A, Jia W (2020) Anti-adipogenic effect of theabrownin is mediated by bile acid alternative synthesis via gut microbiota remodeling. Metabolites 10:1\u201316","journal-title":"Metabolites"},{"key":"4278_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1128\/am.19.2.295-300.1970","volume":"19","author":"DW Yesair","year":"1970","unstructured":"Yesair DW, Himmelfarb P (1970) Hydrolysis of conjugated bile acids by cell-free extracts from aerobic bacteria. Appl Microbiol 19:295\u2013300","journal-title":"Appl Microbiol"},{"key":"4278_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/0005-2760(70)90123-2","volume":"202","author":"V Aries","year":"1970","unstructured":"Aries V, Hill MJ (1970) Degradation of steroids by intestinal bacteria. I Deconjugation of bile salts. Biochim Biophys Acta 202:526\u2013534","journal-title":"Biochim Biophys Acta"},{"key":"4278_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0022-2275(20)38464-9","volume":"29","author":"R Gopal-Srivastava","year":"1988","unstructured":"Gopal-Srivastava R, Hylemon PB (1988) Purification and characterization of bile salt hydrolase from Clostridium perfringens. J Lipid Res 29:1079\u20131085","journal-title":"J Lipid Res"},{"key":"4278_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1348-0421.1981.tb00001.x","volume":"25","author":"N Masuda","year":"1981","unstructured":"Masuda N (1981) Deconjugation of bile salts by bacteroids and clostridium. Microbiol Immunol 25:1\u201311","journal-title":"Microbiol Immunol"},{"key":"4278_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1128\/aem.62.2.656-661.1996","volume":"62","author":"J Van Eldere","year":"1996","unstructured":"Van Eldere J, Celis P, De Pauw G, Lesaffre E, Eyssen H (1996) Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol 62:656\u2013661","journal-title":"Appl Environ Microbiol"},{"key":"4278_CR31","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.4315\/0362-028X-67.12.2772","volume":"67","author":"A Wijaya","year":"2004","unstructured":"Wijaya A, Hermann A, Abriouel H, Specht I, Yousif NM, Holzapfel WH, Franz CM (2004) Cloning of the bile salt hydrolase (bsh) gene from Enterococcus faecium FAIR-E 345 and chromosomal location of bsh genes in food enterococci. J Food Prot 67:2772\u20132778","journal-title":"J Food Prot"},{"key":"4278_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00284-013-0362-1","volume":"67","author":"P Jarocki","year":"2013","unstructured":"Jarocki P, Targo\u0144ski Z (2013) Genetic diversity of bile salt hydrolases among human intestinal bifidobacteria. Curr Microbiol 67:286\u2013292","journal-title":"Curr Microbiol"},{"key":"4278_CR33","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1128\/AEM.66.6.2502-2512.2000","volume":"66","author":"H Tanaka","year":"2000","unstructured":"Tanaka H, Hashiba H, Kok J, Mierau I (2000) Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization. Appl Environ Microbiol 66:2502\u20132512","journal-title":"Appl Environ Microbiol"},{"key":"4278_CR34","first-page":"292","volume":"79","author":"I De Smet","year":"1995","unstructured":"De Smet I, Van Hoorde L, VandeWoestyne M, Christiaens H, Verstraete W (1995) Significance of bile salt hydrolytic activities of Lactobacilli. J Appl Microbiol 79:292\u2013301","journal-title":"J Appl Microbiol"},{"key":"4278_CR35","first-page":"449","volume":"18","author":"HK Oh","year":"2008","unstructured":"Oh HK, Lee JY, Lim SJ, Kim MJ, Kim GB, Kim JH, Hong SK, Kang DK (2008) Molecular cloning and characterization of a bile salt hydrolase from Lactobacillus acidophilus PF01. J Microbiol Biotechnol 18:449\u2013456","journal-title":"J Microbiol Biotechnol"},{"key":"4278_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000198691","volume":"23","author":"G Salvioli","year":"1982","unstructured":"Salvioli G, Salati R, Bondi M, Fratalocchi A, Sala BM, Gibertini A (1982) Bile acid transformation by the intestinal flora and cholesterol saturation in bile effects of Streptococcus faecium administration. Digestion 23:80\u201388","journal-title":"Digestion"},{"key":"4278_CR37","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1128\/aem.42.5.912-915.1981","volume":"42","author":"S Hirano","year":"1981","unstructured":"Hirano S, Masuda N (1981) Transformation of bile acids by Eubacterium lentum. Appl Environ Microbiol 42:912\u2013915","journal-title":"Appl Environ Microbiol"},{"key":"4278_CR38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1194\/jlr.RA120001021","volume":"61","author":"S Marion","year":"2020","unstructured":"Marion S, Desharnais L, Studer N, Dong Y, Notter MD, Poudel S, Menin L, Janowczyk A, Hettich RL, Hapfelmeier S, Bernier-Latmani R (2020) Biogeography of microbial bile acid transformations along the murine gut. J Lipid Res 61:1450\u20131463","journal-title":"J Lipid Res"},{"key":"4278_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0005-2744(76)90068-1","volume":"452","author":"EJ Stellwag","year":"1976","unstructured":"Stellwag EJ, Hylemon PB (1976) Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim Biophys Acta 452:165\u2013176","journal-title":"Biochim Biophys Acta"},{"key":"4278_CR40","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","volume":"105","author":"BV Jones","year":"2008","unstructured":"Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 105:13580\u201313585","journal-title":"Proc Natl Acad Sci USA"},{"key":"4278_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/pathogens3010014","volume":"3","author":"P Gerard","year":"2013","unstructured":"Gerard P (2013) Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 3:14\u201324","journal-title":"Pathogens"},{"key":"4278_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3412\/jsb.34.403","volume":"34","author":"S Hirano","year":"1979","unstructured":"Hirano S, Masuda N, Mukai H, Hirakawa K, Imamura T (1979) Transformation of bile acids by Bacteroides fragilis strains isolated from the human intestine (author\u2019s transl). Nihon Saikingaku Zasshi 34:403\u2013411","journal-title":"Nihon Saikingaku Zasshi"},{"key":"4278_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","volume":"56","author":"SL Long","year":"2017","unstructured":"Long SL, Gahan CGM, Joyce SA (2017) Interactions between gut bacteria and bile in health and disease. Mol Aspects Med 56:54\u201365","journal-title":"Mol Aspects Med"},{"key":"4278_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/19490976.2019.1618173","volume":"11","author":"JM Ridlon","year":"2020","unstructured":"Ridlon JM, Devendran S, Alves JM, Doden H, Wolf PG, Pereira GV, Ly L, Volland A, Takei H, Nittono H, Murai T, Kurosawa T, Chlipala GE, Green SJ, Hernandez AG, Fields CJ, Wright CL, Kakiyama G, Cann I, Kashyap P, McCracken V, Gaskins HR (2020) The \u201cin vivo lifestyle\u201d of bile acid 7\u03b1-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice x. Gut Microbes 11:381\u2013404","journal-title":"Gut Microbes"},{"key":"4278_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1194\/jlr.M020313","volume":"53","author":"JM Ridlon","year":"2012","unstructured":"Ridlon JM, Hylemon PB (2012) Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7\u03b1-dehydroxylating intestinal bacterium. J Lipid Res 53:66\u201376","journal-title":"J Lipid Res"},{"key":"4278_CR46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/BF02533948","volume":"22","author":"T Chikai","year":"1987","unstructured":"Chikai T, Nakao H, Uchida K (1987) Deconjugation of bile acids by human intestinal bacteria implanted in germ-free rats. Lipids 22:669\u2013671","journal-title":"Lipids"},{"key":"4278_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s11745-006-5038-1","volume":"41","author":"S Narushima","year":"2006","unstructured":"Narushima S, Itoha K, Miyamoto Y, Park SH, Nagata K, Kuruma K, Uchida K (2006) Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 41:835\u2013843","journal-title":"Lipids"},{"key":"4278_CR48","first-page":"1016","volume":"17","author":"M Vital","year":"2019","unstructured":"Vital M, Rud T, Rath S, Pieper DH, Schl\u00fcter D (2019) Diversity of bacteria exhibiting bile acid-inducible 7\u03b1-dehydroxylation genes in the human gut, computational and structural. Biotechnol J 17:1016\u20131019","journal-title":"Biotechnol J"},{"key":"4278_CR49","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.5604\/01.3001.0010.5672","volume":"16","author":"O Ram\u00edrez-P\u00e9rez","year":"2017","unstructured":"Ram\u00edrez-P\u00e9rez O, Cruz-Ram\u00f3n V, Chinchilla-L\u00f3pez P, M\u00e9ndez-S\u00e1nchez N (2017) The role of the gut microbiota in bile acid metabolism. Ann Hepatol 16:S21\u2013S26","journal-title":"Ann Hepatol"},{"key":"4278_CR50","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","volume":"29","author":"M Begley","year":"2005","unstructured":"Begley M, Gahan CGM, Hill C (2005) The interaction between bacteria and bile. FEMS Microbiol Rev 29:625\u2013651","journal-title":"FEMS Microbiol Rev"},{"key":"4278_CR51","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1128\/JB.00995-06","volume":"188","author":"M Garcia-Quintanilla","year":"2006","unstructured":"Garcia-Quintanilla M, Prieto AI, Barnes L, Ramos-Morales F, Casadesus J (2006) Bile-induced curing of the virulence plasmid in Salmonella enterica serovar Typhimurium. J Bacteriol 188:7963\u20137965","journal-title":"J Bacteriol"},{"key":"4278_CR52","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1099\/jmm.0.014092-0","volume":"58","author":"ME Merritt","year":"2009","unstructured":"Merritt ME, Donaldson JR (2009) Effect of bile salts on the DNA and membrane integrity of enteric bacteria. J Med Microbiol 58:1533\u20131541","journal-title":"J Med Microbiol"},{"key":"4278_CR53","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1534\/genetics.104.031062","volume":"168","author":"AI Prieto","year":"2004","unstructured":"Prieto AI, Ramos-Morales F, Casadesus J (2004) Bile-induced DNA damage in Salmonella enterica. Genetics 168:1787\u20131794","journal-title":"Genetics"},{"key":"4278_CR54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fmicb.2018.00646","volume":"9","author":"H Schaffler","year":"2018","unstructured":"Schaffler H, Breitruck A (2018) Clostridium difficile\u2014from colonization to infection. Front Microbiol 9:646","journal-title":"Front Microbiol"},{"key":"4278_CR55","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1128\/JB.00610-10","volume":"192","author":"JA Sorg","year":"2010","unstructured":"Sorg JA, Sonenshein AL (2010) Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol 192:4983\u20134990","journal-title":"J Bacteriol"},{"key":"4278_CR56","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1177\/1535370214538743","volume":"239","author":"J Tsuei","year":"2014","unstructured":"Tsuei J, Chau T, Mills D, Wan YJ (2014) Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med 239:1489\u20131504","journal-title":"Exp Biol Med"},{"key":"4278_CR57","first-page":"305","volume":"58","author":"MM Slocum","year":"1992","unstructured":"Slocum MM, Sittig KM, Specian RD, Deitch EA (1992) Absence of intestinal bile promotes bacterial translocation. Am Surg 58:305\u2013310","journal-title":"Am Surg"},{"key":"4278_CR58","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1038\/s41467-020-17183-8","volume":"11","author":"N van Best","year":"2020","unstructured":"van Best N, Rolle-Kampczyk U, Schaap FG, Basic M, Olde Damink SWM, Bleich A, Savelkoul PHM, von Bergen M, Penders J, Hornef MW (2020) Bile acids drive the newborn\u2019s gut microbiota maturation. Nat Commun 11:3692","journal-title":"Nat Commun"},{"key":"4278_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trecan.2015.07.005","volume":"1","author":"RM Thomas","year":"2015","unstructured":"Thomas RM, Jobin C (2015) The microbiome and cancer: is the \u201concobiome\u201d mirage real? Trends in Cancer 1:24\u201335","journal-title":"Trends in Cancer"},{"key":"4278_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10565-016-9320-6","volume":"32","author":"E Miko","year":"2016","unstructured":"Miko E, Vida A, Bai P (2016) Translational aspects of the microbiome-to be exploited. Cell Biol Toxicol 32:153\u2013156","journal-title":"Cell Biol Toxicol"},{"key":"4278_CR61","doi-asserted-by":"publisher","DOI":"10.1556\/2060.2020.00016","author":"Z S\u00e1ri","year":"2020","unstructured":"S\u00e1ri Z, Kov\u00e1cs T, Csonka T, T\u00f6r\u00f6k M, Seb\u0151 \u00c9, Toth J, T\u00f3th D, Mik\u00f3 E, Kiss B, Sze\u0151cs D, Uray K, Kar\u00e1nyi Z, Kov\u00e1cs I, M\u00e9hes G, \u00c1rkosy P, B. P, (2020) Fecal expression of E. coli lysine decarboxylase (LdcC) is downregulated in E-cadherin negative lobular breast carcinoma. Physiol Int. https:\/\/doi.org\/10.1556\/2060.2020.00016","journal-title":"Physiol Int"},{"key":"4278_CR62","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/cancers12102915","volume":"12","author":"Z S\u00e1ri","year":"2020","unstructured":"S\u00e1ri Z, Mik\u00f3 E, Kov\u00e1cs T, Boratk\u00f3 A, Ujlaki G, Jank\u00f3 L, Kiss B, Uray K, Bai P (2020) Indoxylsulfate, a metabolite of the microbiome has cytostatic effects in breast cancer via activation of AHR and PXR receptors and induction of oxidative stress. Cancers (Basel) 12:2915","journal-title":"Cancers (Basel)"},{"key":"4278_CR63","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3390\/cancers12092411","volume":"12","author":"Z S\u00e1ri","year":"2020","unstructured":"S\u00e1ri Z, Mik\u00f3 E, Kov\u00e1cs T, Jank\u00f3 L, Csonka T, Seb\u0151 E, Toth J, T\u00f3th D, \u00c1rkosy P, Boratk\u00f3 A, Ujlaki G, T\u00f6r\u00f6k M, Kov\u00e1cs I, Szab\u00f3 J, Kiss B, M\u00e9hes G, Goedert JJ, Bai P (2020) Indolepropionic acid, a metabolite of the microbiome, has cytostatic properties in breast cancer by activating AHR and PXR receptors and inducing oxidative stress. Cancers (Basel) 12:2411","journal-title":"Cancers (Basel)"},{"key":"4278_CR64","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41598-018-37664-7","volume":"9","author":"T Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs T, Mik\u00f3 E, Vida A, Seb\u0151 \u00c9, Toth J, Csonka T, Boratk\u00f3 A, Ujlaki G, Lente G, Kov\u00e1cs P, T\u00f3th D, \u00c1rkosy P, Kiss B, M\u00e9hes G, Goedert JJ, Bai P (2019) Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors. Sci Rep 9:1300","journal-title":"Sci Rep"},{"key":"4278_CR65","first-page":"2340","volume":"2","author":"PA Dawson","year":"2009","unstructured":"Dawson PA, Lan T, Rao A (2009) Thematic review series: Bile acids Bile acid transporters. Am Soc Biochem Mol Biol 2:2340\u20132357","journal-title":"Am Soc Biochem Mol Biol"},{"key":"4278_CR66","first-page":"252","volume-title":"The solute carrier family 10 (SLC10): Beyond bile acid transport","author":"T Claro Da Silva","year":"2013","unstructured":"Claro Da Silva T, Polli JE, Swaan PW (2013) The solute carrier family 10 (SLC10): Beyond bile acid transport. Pergamon, Berlin, pp 252\u2013269"},{"key":"4278_CR67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000450911","volume":"35","author":"D Keppler","year":"2017","unstructured":"Keppler D (2017) Progress in the molecular characterization of hepatobiliary transporters. Dig Dis 35:197\u2013202","journal-title":"Dig Dis"},{"key":"4278_CR68","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1074\/jbc.M411092200","volume":"280","author":"W Lee","year":"2005","unstructured":"Lee W, Glaeser H, Smith LH, Roberts RL, Moeckel GW, Gervasini G, Leake BF, Kim RB (2005) Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem 280:9610\u20139617","journal-title":"J Biol Chem"},{"key":"4278_CR69","first-page":"396","volume-title":"The SLCO (former SLC21) superfamily of transporters","author":"B Hagenbuch","year":"2013","unstructured":"Hagenbuch B, Stieger B (2013) The SLCO (former SLC21) superfamily of transporters. Place Published, Pergamon, pp 396\u2013412"},{"key":"4278_CR70","doi-asserted-by":"publisher","first-page":"e0169719","DOI":"10.1371\/journal.pone.0169719","volume":"12","author":"T Suga","year":"2017","unstructured":"Suga T, Yamaguchi H, Sato T, Maekawa M, Goto J, Mano N (2017) Preference of conjugated bile acids over unconjugated bile acids as substrates for OATP1B1 and OATP1B3. PLoS ONE 12:e0169719","journal-title":"PLoS ONE"},{"key":"4278_CR71","first-page":"1260","volume-title":"OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","author":"M Roth","year":"2012","unstructured":"Roth M, Obaidat A, Hagenbuch B (2012) OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Wiley-Blackwell, New York, pp 1260\u20131287"},{"key":"4278_CR72","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362\u20131365","journal-title":"Science"},{"key":"4278_CR73","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1074\/jbc.M209706200","volume":"278","author":"Y Kawamata","year":"2003","unstructured":"Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M (2003) A G protein-coupled receptor responsive to bile acids. J Biol Chem 278:9435\u20139440","journal-title":"J Biol Chem"},{"key":"4278_CR74","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","volume":"298","author":"T Maruyama","year":"2002","unstructured":"Maruyama T, Miyamoto Y, Nakamura T, Tamai Y, Okada H, Sugiyama E, Nakamura T, Itadani H, Tanaka K (2002) Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 298:714\u2013719","journal-title":"Biochem Biophys Res Commun"},{"key":"4278_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, Paik D, Yao L, Kim E, Trinath J, Lu J, Ha S, Nelson BN, Kelly SP, Wu L, Zheng Y, Longman RS, Rastinejad F, Devlin AS, Krout MR, Fischbach MA, Littman DR, Huh JR (2019) Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576:143\u2013148","journal-title":"Nature"},{"key":"4278_CR76","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mam.2017.05.003","volume":"56","author":"S McIlvride","year":"2017","unstructured":"McIlvride S, Dixon PH, Williamson C (2017) Bile acids and gestation. Mol Aspects Med 56:90\u2013100","journal-title":"Mol Aspects Med"},{"key":"4278_CR77","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/hep.23032","volume":"50","author":"V Keitel","year":"2009","unstructured":"Keitel V, Cupisti K, Ullmer C, Knoefel WT, Kubitz R, H\u00e4ussinger D (2009) The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology 50:861\u2013870","journal-title":"Hepatology"},{"key":"4278_CR78","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1365-2982.2010.01487.x","volume":"22","author":"DP Poole","year":"2010","unstructured":"Poole DP, Godfrey C, Cattaruzza F, Cottrell GS, Kirkland JG, Pelayo JC, Bunnett NW, Corvera CU (2010) Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil 22:814\u2013825","journal-title":"Neurogastroenterol Motil"},{"key":"4278_CR79","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","volume":"372","author":"V Keitel","year":"2008","unstructured":"Keitel V, Donner M, Winandy S, Kubitz R, H\u00e4ussinger D (2008) Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun 372:78\u201384","journal-title":"Biochem Biophys Res Commun"},{"key":"4278_CR80","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbrc.2007.06.130","volume":"362","author":"H Sato","year":"2007","unstructured":"Sato H, Genet C, Strehle A, Thomas C, Lobstein A, Wagner A, Mioskowski C, Auwerx J, Saladin R (2007) Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem Biophys Res Commun 362:793\u2013798","journal-title":"Biochem Biophys Res Commun"},{"key":"4278_CR81","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1021\/jm901390p","volume":"52","author":"R Pellicciari","year":"2009","unstructured":"Pellicciari R, Gioiello A, Macchiarulo A, Thomas C, Rosatelli E, Natalini B, Sardella R, Pruzanski M, Roda A, Pastorini E, Schoonjans K, Auwerx J (2009) Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J Med Chem 52:7958\u20137961","journal-title":"J Med Chem"},{"key":"4278_CR82","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1124\/mol.110.064501","volume":"78","author":"G Rizzo","year":"2010","unstructured":"Rizzo G, Passeri D, De Franco F, Ciaccioli G, Donadio L, Rizzo G, Orlandi S, Sadeghpour B, Wang XX, Jiang T, Levi M, Pruzanski M, Adorini L (2010) Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist. Mol Pharmacol 78:617\u2013630","journal-title":"Mol Pharmacol"},{"key":"4278_CR83","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1021\/jm900872z","volume":"53","author":"C Genet","year":"2010","unstructured":"Genet C, Strehle A, Schmidt C, Boudjelal G, Lobstein A, Schoonjans K, Souchet M, Auwerx J, Saladin R, Wagner A (2010) Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes. J Med Chem 53:178\u2013190","journal-title":"J Med Chem"},{"key":"4278_CR84","first-page":"1","volume":"10","author":"C Zheng","year":"2015","unstructured":"Zheng C, Zhou W, Wang T, You P, Zhao Y, Yang Y, Wang X, Luo J, Chen Y, Liu M, Chen H (2015) A novel TGR5 activator WB403 promotes GLP-1 secretion and preserves pancreatic \u03b2- Cells in type 2 diabetic mice. PLoS ONE 10:1\u201316","journal-title":"PLoS ONE"},{"key":"4278_CR85","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","volume":"54","author":"TWH Pols","year":"2011","unstructured":"Pols TWH, Noriega LG, Nomura M, Auwerx J, Schoonjans K (2011) The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 54:1263\u20131272","journal-title":"J Hepatol"},{"key":"4278_CR86","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","volume":"65","author":"M Reich","year":"2016","unstructured":"Reich M, Deutschmann K, Sommerfeld A, Klindt C, Kluge S, Kubitz R, Ullmer C, Knoefel WT, Herebian D, Mayatepek E, H\u00e4ussinger D, Keitel V (2016) TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro. Gut 65:487\u2013501","journal-title":"Gut"},{"key":"4278_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1152\/ajpgi.00383.2012","volume":"304","author":"AI Masyuk","year":"2013","unstructured":"Masyuk AI, Huang BQ, Radtke BN, Gajdos GB, Splinter PL, Masyuk TV, Gradilone SA, LaRusso NF (2013) Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling. Am J Physiol Gastrointest Liver Physiol 304:2","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR88","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1172\/JCI76289","volume":"124","author":"A Perino","year":"2014","unstructured":"Perino A, Pols TWH, Nomura M, Stein S, Pellicciari R, Schoonjans K (2014) TGR5 reduces macrophage migration through mTOR-induced C\/EBP\u03b2 differential translation. J Clin Investig 124:5424\u20135436","journal-title":"J Clin Investig"},{"key":"4278_CR89","doi-asserted-by":"publisher","first-page":"G527","DOI":"10.1152\/ajpgi.00388.2012","volume":"304","author":"S Rajagopal","year":"2013","unstructured":"Rajagopal S, Kumar DP, Mahavadi S, Bhattacharya S, Zhou R, Corvera CU, Bunnett NW, Grider JR, Murthy KS (2013) Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA\/Rho kinase pathway. Am J Physiol Gastrointest Liver Physiol 304:G527-535","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR90","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1677\/joe.1.06546","volume":"191","author":"T Maruyama","year":"2006","unstructured":"Maruyama T, Tanaka K, Suzuki J, Miyoshi H, Harada N, Nakamura T, Miyamoto Y, Kanatani A, Tamai Y (2006) Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1\/M-Bar) in mice. J Endocrinol 191:197\u2013205","journal-title":"J Endocrinol"},{"key":"4278_CR91","doi-asserted-by":"publisher","first-page":"34402","DOI":"10.18632\/oncotarget.5353","volume":"6","author":"C Guo","year":"2015","unstructured":"Guo C, Su J, Li Z, Xiao R, Wen J, Li Y, Zhang M, Zhang X, Yu D, Huang W, Chen WD, Wang YD (2015) The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway. Oncotarget 6:34402\u201334413","journal-title":"Oncotarget"},{"key":"4278_CR92","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"YD Wang","year":"2011","unstructured":"Wang YD, Chen WD, Yu D, Forman BM, Huang W (2011) The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-\u03baB) in mice. Hepatology 54:1421\u20131432","journal-title":"Hepatology"},{"key":"4278_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2016.00646","volume":"7","author":"C Guo","year":"2016","unstructured":"Guo C, Chen WD, Wang YD (2016) TGR5, not only a metabolic regulator. Front Physiol 7:1\u20139","journal-title":"Front Physiol"},{"key":"4278_CR94","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","volume":"14","author":"TWH Pols","year":"2011","unstructured":"Pols TWH, Nomura M, Harach T, Lo Sasso G, Oosterveer MH, Thomas C, Rizzo G, Gioiello A, Adorini L, Pellicciari R, Auwerx J, Schoonjans K (2011) TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab 14:747\u2013757","journal-title":"Cell Metab"},{"key":"4278_CR95","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/hep.27085","volume":"60","author":"R Liu","year":"2014","unstructured":"Liu R, Zhao R, Zhou X, Liang X, Campbell DJW, Zhang X, Zhang L, Shi R, Wang G, Pandak WM, Sirica AE, Hylemon PB, Zhou H (2014) Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. Hepatology 60:908\u2013918","journal-title":"Hepatology"},{"key":"4278_CR96","doi-asserted-by":"publisher","first-page":"30988","DOI":"10.1074\/jbc.M115.668277","volume":"290","author":"R Liu","year":"2015","unstructured":"Liu R, Li X, Qiang X, Luo L, Hylemon PB, Jiang Z, Zhang L, Zhou H (2015) Taurocholate induces cyclooxygenase-2 expression via the sphingosine 1-phosphate receptor 2 in a human cholangiocarcinoma cell line. J Biol Chem 290:30988\u201331002","journal-title":"J Biol Chem"},{"key":"4278_CR97","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/hep.24681","volume":"55","author":"E Studer","year":"2012","unstructured":"Studer E, Zhou X, Zhao R, Wang Y, Takabe K, Nagahashi M, Pandak WM, Dent P, Spiegel S, Shi R, Xu W, Liu X, Bohdan P, Zhang L, Zhou H, Hylemon PB (2012) Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 55:267\u2013276","journal-title":"Hepatology"},{"key":"4278_CR98","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/hep.27592","volume":"61","author":"M Nagahashi","year":"2015","unstructured":"Nagahashi M, Takabe K, Liu R, Peng K, Wang X, Wang Y, Hait NC, Wang X, Allegood JC, Yamada A, Aoyagi T, Liang J, Pandak WM, Spiegel S, Hylemon PB, Zhou H (2015) Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology 61:1216\u20131226","journal-title":"Hepatology"},{"key":"4278_CR99","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1194\/jlr.R069286","volume":"57","author":"M Nagahashi","year":"2016","unstructured":"Nagahashi M, Yuza K, Hirose Y, Nakajima M, Ramanathan R, Hait NC, Hylemon PB, Zhou H, Takabe K, Wakai T (2016) The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. J Lipid Res 57:1636\u20131643","journal-title":"J Lipid Res"},{"key":"4278_CR100","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1159\/000493611","volume":"49","author":"J Yang","year":"2018","unstructured":"Yang J, Yang L, Tian L, Ji X, Yang L, Li L (2018) Sphingosine 1-phosphate (S1P)\/S1P receptor 2\/3 axis promotes inflammatory M1 polarization of bone marrow-derived monocyte\/macrophage via G(\u03b1) i\/o \/PI3K\/JNK pathway. Cell Physiol Biochem 49:1677\u20131693","journal-title":"Cell Physiol Biochem"},{"key":"4278_CR101","first-page":"1922","volume":"2013","author":"G Karimian","year":"1832","unstructured":"Karimian G, Buist-Homan M, Schmidt M, Tietge UJF, de Boer JF, Klappe K, Kok JW, Combettes L, Tordjmann T, Faber KN, Moshage H (1832) Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. Biochim Biophys Acta Mol Basis Dis 2013:1922\u20131929","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4278_CR102","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/CIRCRESAHA.107.170779","volume":"102","author":"JE Hughes","year":"2008","unstructured":"Hughes JE, Srinivasan S, Lynch KR, Proia RL, Ferdek P, Hedrick CC (2008) Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 102:950\u2013958","journal-title":"Circ Res"},{"key":"4278_CR103","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/ni.1682","volume":"10","author":"IL Grigorova","year":"2009","unstructured":"Grigorova IL, Schwab SR, Phan TG, Pham TH, Okada T, Cyster JG (2009) Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat Immunol 10:58\u201365","journal-title":"Nat Immunol"},{"key":"4278_CR104","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/cancers3010971","volume":"3","author":"EC von Rosenvinge","year":"2011","unstructured":"von Rosenvinge EC, Raufman JP (2011) Muscarinic receptor signaling in colon cancer. Cancers 3:971\u2013981","journal-title":"Cancers"},{"key":"4278_CR105","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0925-4439(02)00115-1","volume":"1588","author":"K Cheng","year":"2002","unstructured":"Cheng K, Chen Y, Zimniak P, Raufman JP, Xiao Y, Frucht H (2002) Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line. Biochim Biophys Acta Mol Basis Dis 1588:48\u201355","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4278_CR106","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3892\/ijo.2015.2939","volume":"46","author":"S Amonyingcharoen","year":"2015","unstructured":"Amonyingcharoen S, Suriyo T, Thiantanawat A, Watcharasit P, Satayavivad J (2015) Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR\/ERK1\/2 signaling pathway. Int J Oncol 46:2317\u20132326","journal-title":"Int J Oncol"},{"key":"4278_CR107","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","volume":"81","author":"BM Forman","year":"1995","unstructured":"Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687\u2013693","journal-title":"Cell"},{"key":"4278_CR108","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","volume":"272","author":"W Seol","year":"1996","unstructured":"Seol W, Choi HS, Moore DD (1996) An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336\u20131339","journal-title":"Science"},{"key":"4278_CR109","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517\u2013526","journal-title":"Mol Cell"},{"key":"4278_CR110","doi-asserted-by":"publisher","first-page":"41690","DOI":"10.1074\/jbc.M105117200","volume":"276","author":"M Zhang","year":"2001","unstructured":"Zhang M, Chiang JYL (2001) Transcriptional regulation of the human sterol 12\u03b1-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4\u03b1 in mediating bile acid repression. J Biol Chem 276:41690\u201341699","journal-title":"J Biol Chem"},{"key":"4278_CR111","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.25740","volume":"56","author":"B Kong","year":"2012","unstructured":"Kong B, Wang L, Chiang JYL, Zhang Y, Klaassen CD, Guo GL (2012) Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 56:1034\u20131043","journal-title":"Hepatology"},{"key":"4278_CR112","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/gast.2001.25503","volume":"121","author":"LA Denson","year":"2001","unstructured":"Denson LA, Sturm E, Echevarria W, Zimmerman TL, Makishima M, Mangelsdorf DJ, Karpen SJ (2001) The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121:140\u2013147","journal-title":"Gastroenterology"},{"key":"4278_CR113","doi-asserted-by":"publisher","first-page":"28857","DOI":"10.1074\/jbc.M011610200","volume":"276","author":"M Ananthanarayanan","year":"2001","unstructured":"Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, Suchy FJ (2001) Human bile salt export pump promoter is transactivated by the Farnesoid X receptor\/bile acid receptor. J Biol Chem 276:28857\u201328865","journal-title":"J Biol Chem"},{"key":"4278_CR114","doi-asserted-by":"publisher","first-page":"29749","DOI":"10.1074\/jbc.274.42.29749","volume":"274","author":"J Grobert","year":"1999","unstructured":"Grobert J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, Ono T, Besnard P (1999) Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor\/9-cis- retinoic acid receptor heterodimer. J Biol Chem 274:29749\u201329754","journal-title":"J Biol Chem"},{"key":"4278_CR115","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00008571-200410000-00001","volume":"14","author":"C Gnerre","year":"2004","unstructured":"Gnerre C, Bl\u00e4ttler S, Kaufmann MR, Looser R, Meyer UA (2004) Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics 14:635\u2013645","journal-title":"Pharmacogenetics"},{"key":"4278_CR116","doi-asserted-by":"publisher","first-page":"42549","DOI":"10.1074\/jbc.M107557200","volume":"276","author":"CS Song","year":"2001","unstructured":"Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, Chatterjee B (2001) Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J Biol Chem 276:42549\u201342556","journal-title":"J Biol Chem"},{"key":"4278_CR117","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/S0016-5085(03)00388-3","volume":"124","author":"O Barbier","year":"2003","unstructured":"Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B (2003) FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926\u20131940","journal-title":"Gastroenterology"},{"key":"4278_CR118","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.22519","volume":"48","author":"YD Wang","year":"2008","unstructured":"Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W (2008) Farnesoid X receptor antagonizes nuclear factor \u03baB in hepatic inflammatory response. Hepatology 48:1632\u20131643","journal-title":"Hepatology"},{"key":"4278_CR119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.taap.2003.12.027","volume":"199","author":"V Lamba","year":"2004","unstructured":"Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S, Schuetz EG (2004) PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 199:251\u2013265","journal-title":"Toxicol Appl Pharmacol"},{"key":"4278_CR120","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1517\/17425255.2012.685237","volume":"8","author":"YM Wang","year":"2012","unstructured":"Wang YM, Ong SS, Chai SC, Chen T (2012) Role of CAR and PXR in xenobiotic sensing and metabolism. Expert Opin Drug Metab Toxicol 8:803\u2013817","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4278_CR121","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1053\/j.gastro.2011.02.055","volume":"140","author":"J He","year":"2011","unstructured":"He J, Nishida S, Xu M, Makishima M, Xie W (2011) PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 140:2095\u20132106","journal-title":"Gastroenterology"},{"key":"4278_CR122","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1073\/pnas.051551698","volume":"98","author":"JL Staudinger","year":"2001","unstructured":"Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, Willson TM, Koller BH, Kliewer SA (2001) The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98:3369\u20133374","journal-title":"Proc Natl Acad Sci USA"},{"key":"4278_CR123","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.3748\/wjg.v13.i31.4230","volume":"13","author":"W Wistuba","year":"2007","unstructured":"Wistuba W, Gnewuch C, Liebisch G, Schmitz G, Langmann T (2007) Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR. World J Gastroenterol 13:4230\u20134235","journal-title":"World J Gastroenterol"},{"key":"4278_CR124","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1073\/pnas.051014398","volume":"98","author":"W Xie","year":"2001","unstructured":"Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, Waxman DJ, Evans RM (2001) An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98:3375\u20133380","journal-title":"Proc Natl Acad Sci USA"},{"key":"4278_CR125","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","volume":"130","author":"JW Jonker","year":"2012","unstructured":"Jonker JW, Liddle C, Downes M (2012) FXR and PXR: potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol 130:147\u2013158","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4278_CR126","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1152\/ajpgi.00258.2004","volume":"288","author":"T Li","year":"2005","unstructured":"Li T, Chiang JYL (2005) Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7\u03b1-hydroxylase gene transcription. Am J Physiol Gastrointest Liver Physiol 288:74\u201384","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR127","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jsbmb.2010.04.012","volume":"120","author":"K Wallace","year":"2010","unstructured":"Wallace K, Cowie DE, Konstantinou DK, Hill SJ, Tjelle TE, Axon A, Koruth M, White SA, Carlsen H, Mann DA, Wright MC (2010) The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol 120:137\u2013148","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4278_CR128","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2174\/138920008785821666","volume":"9","author":"S Kakizaki","year":"2008","unstructured":"Kakizaki S, Yamazaki Y, Takizawa D, Negishi M (2008) New insights on the xenobiotic-sensing nuclear receptors in liver diseases\u2013CAR and PXR. Curr Drug Metab 9:614\u2013621","journal-title":"Curr Drug Metab"},{"key":"4278_CR129","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tips.2012.03.003","volume":"33","author":"J Cheng","year":"2012","unstructured":"Cheng J, Shah YM, Gonzalez FJ (2012) Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci 33:323\u2013330","journal-title":"Trends Pharmacol Sci"},{"key":"4278_CR130","doi-asserted-by":"publisher","first-page":"15013","DOI":"10.1074\/jbc.M511116200","volume":"281","author":"J Zhou","year":"2006","unstructured":"Zhou J, Zhai Y, Mu Y, Gong H, Uppal H, Toma D, Ren S, Evans RM, Xie W (2006) A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J Biol Chem 281:15013\u201315020","journal-title":"J Biol Chem"},{"key":"4278_CR131","doi-asserted-by":"publisher","first-page":"9768","DOI":"10.1074\/jbc.M610072200","volume":"282","author":"K Nakamura","year":"2007","unstructured":"Nakamura K, Moore R, Negishi M, Sueyoshi T (2007) Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. J Biol Chem 282:9768\u20139776","journal-title":"J Biol Chem"},{"key":"4278_CR132","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1042\/BJ20070481","volume":"407","author":"S Kodama","year":"2007","unstructured":"Kodama S, Moore R, Yamamoto Y, Negishi M (2007) Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochemical Journal 407:373\u2013381","journal-title":"Biochemical Journal"},{"key":"4278_CR133","doi-asserted-by":"publisher","first-page":"45139","DOI":"10.1074\/jbc.M405423200","volume":"279","author":"S Bhalla","year":"2004","unstructured":"Bhalla S, Ozalp C, Fang S, Xiang L, Kemper JK (2004) Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1\u03b1. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem 279:45139\u201345147","journal-title":"J Biol Chem"},{"key":"4278_CR134","doi-asserted-by":"publisher","first-page":"23565","DOI":"10.1074\/jbc.272.38.23565","volume":"272","author":"HS Choi","year":"1997","unstructured":"Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, Moore DD (1997) Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem 272:23565\u201323571","journal-title":"J Biol Chem"},{"key":"4278_CR135","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/26996","volume":"395","author":"BM Forman","year":"1998","unstructured":"Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR- \u03b2. Nature 395:612\u2013615","journal-title":"Nature"},{"key":"4278_CR136","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1517\/17425251003598886","volume":"6","author":"H Li","year":"2010","unstructured":"Li H, Wang H (2010) Activation of xenobiotic receptors: Driving into the nucleus. Expert Opin Drug Metab Toxicol 6:409\u2013426","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4278_CR137","first-page":"1544","volume":"14","author":"M Baes","year":"1994","unstructured":"Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14:1544\u20131552","journal-title":"Mol Cell Biol"},{"key":"4278_CR138","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mam.2009.04.002","volume":"30","author":"A di Masi","year":"2009","unstructured":"di Masi A, De Marinis E, Ascenzi P, Marino M (2009) Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects. Mol Aspects Med 30:297\u2013343","journal-title":"Mol Aspects Med"},{"key":"4278_CR139","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/hep.20784","volume":"42","author":"M Wagner","year":"2005","unstructured":"Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M (2005) CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42:420\u2013430","journal-title":"Hepatology"},{"key":"4278_CR140","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1124\/dmd.108.025155","volume":"37","author":"S Han","year":"2009","unstructured":"Han S, Chiang JY (2009) Mechanism of vitamin D receptor inhibition of cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos 37:469\u2013478","journal-title":"Drug Metab Dispos"},{"key":"4278_CR141","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1152\/physiolgenomics.00151.2012","volume":"45","author":"Z Li","year":"2013","unstructured":"Li Z, Kar Kruijt J, van der Sluis RJ, Van Berkel TJC, Hoekstra M (2013) Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells. Physiol Genom 45:268\u2013275","journal-title":"Physiol Genom"},{"key":"4278_CR142","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1210\/en.2006-0946","volume":"147","author":"AW Norman","year":"2006","unstructured":"Norman AW (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147:5542\u20135548","journal-title":"Endocrinology"},{"key":"4278_CR143","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1126\/science.1070477","volume":"296","author":"M Makishima","year":"2002","unstructured":"Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ (2002) Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313\u20131316","journal-title":"Science"},{"key":"4278_CR144","doi-asserted-by":"publisher","first-page":"10006","DOI":"10.1073\/pnas.0703512104","volume":"104","author":"JA Nehring","year":"2007","unstructured":"Nehring JA, Zierold C, DeLuca HF (2007) Lithocholic acid can carry out in vivo functions of vitamin D. Proc Natl Acad Sci USA 104:10006\u201310009","journal-title":"Proc Natl Acad Sci USA"},{"key":"4278_CR145","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1194\/jlr.M044420","volume":"55","author":"J Cheng","year":"2014","unstructured":"Cheng J, Fang ZZ, Kim JH, Krausz KW, Tanaka N, Chiang JYL, Gonzalez FJ (2014) Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice. J Lipid Res 55:455\u2013465","journal-title":"J Lipid Res"},{"key":"4278_CR146","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0076-6879(05)00010-8","volume":"400","author":"B Chatterjee","year":"2005","unstructured":"Chatterjee B, Echchgadda I, Song CS (2005) Vitamin D receptor regulation of the steroid\/bile acid sulfotransferase SULT2A1. Methods Enzymol 400:165\u2013191","journal-title":"Methods Enzymol"},{"key":"4278_CR147","doi-asserted-by":"publisher","first-page":"23232","DOI":"10.1074\/jbc.M411520200","volume":"280","author":"TC McCarthy","year":"2005","unstructured":"McCarthy TC, Li X, Sinal CJ (2005) Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 280:23232\u201323242","journal-title":"J Biol Chem"},{"key":"4278_CR148","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1124\/mol.105.020792","volume":"69","author":"X Chen","year":"2006","unstructured":"Chen X, Chen F, Liu S, Glaeser H, Dawson PA, Hofmann AF, Kim RB, Shneider BL, Pang KS (2006) Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor. Mol Pharmacol 69:1913\u20131923","journal-title":"Mol Pharmacol"},{"key":"4278_CR149","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1210\/me.2004-0116","volume":"18","author":"JA Huhtakangas","year":"2004","unstructured":"Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW (2004) The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1\u03b1,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18:2660\u20132671","journal-title":"Mol Endocrinol"},{"key":"4278_CR150","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1210\/me.2009-0482","volume":"24","author":"S Han","year":"2010","unstructured":"Han S, Li T, Ellis E, Strom S, Chiang JY (2010) A novel bile acid-activated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol 24:1151\u20131164","journal-title":"Mol Endocrinol"},{"key":"4278_CR151","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1053\/j.gastro.2008.12.040","volume":"136","author":"E Daldebert","year":"2009","unstructured":"Daldebert E, Biyeyeme MJ, Mve B, Mergey M, Wendum D, Firrincieli D, Coilly A, Fouassier L, Corpechot C, Poupon R, Housset C, Chignard N (2009) Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 136:1435\u20131443","journal-title":"Gastroenterology"},{"key":"4278_CR152","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1210\/er.2004-0002","volume":"26","author":"S Nagpal","year":"2005","unstructured":"Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662\u2013687","journal-title":"Endocr Rev"},{"key":"4278_CR153","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/383728a0","volume":"383","author":"BA Janowski","year":"1996","unstructured":"Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728\u2013731","journal-title":"Nature"},{"key":"4278_CR154","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1093\/emboj\/cdg456","volume":"22","author":"S Svensson","year":"2003","unstructured":"Svensson S, \u00d6stberg T, Jacobsson M, Norstr\u00f6m C, Stefansson K, Hall\u00e9n D, Johansson IC, Zachrisson K, Ogg D, Jendeberg L (2003) Crystal structure of the heterodimeric complex of LXR\u03b1 and RXR\u03b2 ligand-binding domains in a fully agonistic conformation. EMBO J 22:4625\u20134633","journal-title":"EMBO J"},{"key":"4278_CR155","doi-asserted-by":"publisher","first-page":"12097","DOI":"10.1073\/pnas.200367697","volume":"97","author":"A Venkateswaran","year":"2000","unstructured":"Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR\u03b1. Proc Natl Acad Sci USA 97:12097\u201312102","journal-title":"Proc Natl Acad Sci USA"},{"key":"4278_CR156","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2004.09.032","volume":"119","author":"SB Joseph","year":"2004","unstructured":"Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, Hogenesch J, O\u2019Connell RM, Cheng G, Saez E, Miller JF, Tontonoz P (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299\u2013309","journal-title":"Cell"},{"key":"4278_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep43290","volume":"7","author":"S De Marino","year":"2017","unstructured":"De Marino S, Carino A, Masullo D, Finamore C, Marchian\u00f2 S, Cipriani S, Di Leva FS, Catalanotti B, Novellino E, Limongelli V, Fiorucci S, Zampella A (2017) Hyodeoxycholic acid derivatives as liver X receptor \u03b1 and G-protein-coupled bile acid receptor agonists. Sci Rep 7:1\u201313","journal-title":"Sci Rep"},{"key":"4278_CR158","first-page":"893","volume":"2011","author":"Y Zhang","year":"1812","unstructured":"Zhang Y, Hagedorn CH, Wang L (1812) Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta Mol Basis Dis 2011:893\u2013908","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4278_CR159","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1101\/gad.1773909","volume":"23","author":"J Miao","year":"2009","unstructured":"Miao J, Xiao Z, Kanamaluru D, Min G, Yau PM, Veenstra TD, Ellis E, Strom S, Suino-Powell K, Xu HE, Kemper JK (2009) Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev 23:986\u2013996","journal-title":"Genes Dev"},{"key":"4278_CR160","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1128\/MCB.00825-09","volume":"29","author":"J Miao","year":"2009","unstructured":"Miao J, Fang S, Lee J, Comstock C, Knudsen KE, Kemper JK (2009) Functional Specificities of Brm and Brg-1 Swi\/Snf ATPases in the Feedback Regulation of Hepatic Bile Acid Biosynthesis. Mol Cell Biol 29:6170\u20136181","journal-title":"Mol Cell Biol"},{"key":"4278_CR161","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1042\/BJ20091445","volume":"427","author":"KJ Kim","year":"2010","unstructured":"Kim KJ, Kim KH, Cho HK, Kim HY, Kim HH, Cheong JH (2010) SHP (small heterodimer partner) suppresses the transcriptional activity and nuclear localization of Hedgehog signalling protein Gli1. Biochemical Journal 427:413\u2013422","journal-title":"Biochemical Journal"},{"key":"4278_CR162","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/gut.32.10.1093","volume":"32","author":"DC Gotley","year":"1991","unstructured":"Gotley DC, Morgan AP, Ball D, Owen RW, Cooper MJ (1991) Composition of gastro-oesophageal refluxate. Gut 32:1093\u20131099","journal-title":"Gut"},{"key":"4278_CR163","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/gut.44.5.598","volume":"44","author":"D Nehra","year":"1999","unstructured":"Nehra D, Howell P, Williams CP, Pye JK, Beynon J (1999) Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44:598\u2013602","journal-title":"Gut"},{"key":"4278_CR164","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/gut.2009.188375","volume":"59","author":"J Hong","year":"2010","unstructured":"Hong J, Behar J, Wands J, Resnick M, Wang LJ, DeLellis RA, Lambeth D, Souza RF, Spechler SJ, Cao W (2010) Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 59:170\u2013180","journal-title":"Gut"},{"key":"4278_CR165","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.ajpath.2018.05.015","volume":"188","author":"R Liu","year":"2018","unstructured":"Liu R, Li X, Hylemon PB, Zhou H (2018) Conjugated bile acids promote invasive growth of esophageal adenocarcinoma cells and cancer stem cell expansion via sphingosine 1-phosphate receptor 2-mediated yes-associated protein activation. Am J Pathol 188:2042\u20132058","journal-title":"Am J Pathol"},{"key":"4278_CR166","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.humpath.2014.02.029","volume":"45","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Xia Y, Bandla S, Zakharov V, Wu S, Peters J, Godfrey TE, Sun J (2014) Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference. Hum Pathol 45:1744\u20131751","journal-title":"Hum Pathol"},{"key":"4278_CR167","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1476-4598-5-48","volume":"5","author":"A De Gottardi","year":"2006","unstructured":"De Gottardi A, Dumonceau JM, Bruttin F, Vonlaufen A, Morard I, Spahr L, Rubbia-Brandt L, Frossard JL, Dinjens WN, Rabinovitch PS, Hadengue A (2006) Expression of the bile acid receptor FXR in Barrett\u2019s esophagus and enhancement of apoptosis by guggulsterone in vitro. Mol Cancer 5:48","journal-title":"Mol Cancer"},{"key":"4278_CR168","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/cncr.27910","volume":"119","author":"B Guan","year":"2013","unstructured":"Guan B, Li H, Yang Z, Hoque A, Xu X (2013) Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts. Cancer 119:1321\u20131329","journal-title":"Cancer"},{"key":"4278_CR169","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/CEG.S117842","volume":"10","author":"C Pang","year":"2017","unstructured":"Pang C, LaLonde A, Godfrey TE, Que J, Sun J, Wu TT, Zhou Z (2017) Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences. Clin Exp Gastroenterol 10:29\u201337","journal-title":"Clin Exp Gastroenterol"},{"key":"4278_CR170","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/j.1572-0241.2008.01908.x","volume":"103","author":"A Capello","year":"2008","unstructured":"Capello A, Moons LM, Van de Winkel A, Siersema PD, van Dekken H, Kuipers EJ, Kusters JG (2008) Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus. Am J Gastroenterol 103:1510\u20131516","journal-title":"Am J Gastroenterol"},{"key":"4278_CR171","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1038\/s41388-018-0388-8","volume":"37","author":"AA Bhat","year":"2018","unstructured":"Bhat AA, Lu H, Soutto M, Capobianco A, Rai P, Zaika A, El-Rifai W (2018) Exposure of Barrett\u2019s and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1. Oncogene 37:6011\u20136024","journal-title":"Oncogene"},{"key":"4278_CR172","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.gastro.2018.09.046","volume":"156","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Agoston AT, Pham TH, Zhang W, Zhang X, Huo X, Peng S, Bajpai M, Das K, Odze RD, Spechler SJ, Souza RF (2019) Acidic bile salts induce epithelial to mesenchymal transition via VEGF signaling in non-neoplastic Barrett\u2019s cells. Gastroenterology 156:130-144.e110","journal-title":"Gastroenterology"},{"key":"4278_CR173","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-018-1021-y","volume":"38","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Lu H, Zhu S, Gomaa A, Chen Z, Yan J, Washington K, El-Rifai W, Dang C, Peng D (2019) Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage. J Exp Clin Cancer Res CR 38:13","journal-title":"J Exp Clin Cancer Res CR"},{"key":"4278_CR174","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","volume":"13","author":"P Correa","year":"2012","unstructured":"Correa P, Piazuelo MB (2012) The gastric precancerous cascade. J Dig Dis 13:2\u20139","journal-title":"J Dig Dis"},{"key":"4278_CR175","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/den.12030","volume":"25","author":"T Matsuhisa","year":"2013","unstructured":"Matsuhisa T, Arakawa T, Watanabe T, Tokutomi T, Sakurai K, Okamura S, Chono S, Kamada T, Sugiyama A, Fujimura Y, Matsuzawa K, Ito M, Yasuda M, Ota H, Haruma K (2013) Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. Dig Endosc 25:519\u2013525","journal-title":"Dig Endosc"},{"key":"4278_CR176","first-page":"879","volume":"54","author":"JH Yu","year":"2019","unstructured":"Yu JH, Zheng JB, Qi J, Yang K, Wu YH, Wang K, Wang CB, Sun XJ (2019) Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR\/NF-\u03baB signalling pathway. Int J Oncol 54:879\u2013892","journal-title":"Int J Oncol"},{"key":"4278_CR177","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3164\/jcbn.09-71","volume":"46","author":"Y Xu","year":"2010","unstructured":"Xu Y, Watanabe T, Tanigawa T, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Arakawa T (2010) Bile acids induce cdx2 expression through the farnesoid x receptor in gastric epithelial cells. J Clin Biochem Nutr 46:81\u201386","journal-title":"J Clin Biochem Nutr"},{"key":"4278_CR178","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/carcin\/bgn207","volume":"29","author":"MJ Park","year":"2008","unstructured":"Park MJ, Kim KH, Kim HY, Kim K, Cheong J (2008) Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells. Carcinogenesis 29:2385\u20132393","journal-title":"Carcinogenesis"},{"key":"4278_CR179","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cam4.999","volume":"6","author":"X Wang","year":"2017","unstructured":"Wang X, Sun L, Wang X, Kang H, Ma X, Wang M, Lin S, Liu M, Dai C, Dai Z (2017) Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c-Myc expression. Cancer Med 6:788\u2013797","journal-title":"Cancer Med"},{"key":"4278_CR180","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3892\/or.2015.3908","volume":"33","author":"X Wang","year":"2015","unstructured":"Wang X, Zhou P, Sun X, Zheng J, Wei G, Zhang L, Wang H, Yao J, Lu S, Jia P (2015) Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells. Oncol Rep 33:3038\u20133044","journal-title":"Oncol Rep"},{"key":"4278_CR181","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-020-0290-3","volume":"6","author":"Z Ni","year":"2020","unstructured":"Ni Z, Min Y, Han C, Yuan T, Lu W, Ashktorab H, Smoot DT, Wu Q, Wu J, Zeng W, Shi Y (2020) TGR5-HNF4alpha axis contributes to bile acid-induced gastric intestinal metaplasia markers expression. Cell Death Discovery 6:56","journal-title":"Cell Death Discovery"},{"key":"4278_CR182","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2006.12.168","volume":"354","author":"H Yasuda","year":"2007","unstructured":"Yasuda H, Hirata S, Inoue K, Mashima H, Ohnishi H, Yoshiba M (2007) Involvement of membrane-type bile acid receptor M-BAR\/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. Biochem Biophys Res Commun 354:154\u2013159","journal-title":"Biochem Biophys Res Commun"},{"key":"4278_CR183","doi-asserted-by":"publisher","first-page":"61021","DOI":"10.18632\/oncotarget.10477","volume":"7","author":"A Carino","year":"2016","unstructured":"Carino A, Graziosi L, D\u2019Amore C, Cipriani S, Marchiano S, Marino E, Zampella A, Rende M, Mosci P, Distrutti E, Donini A, Fiorucci S (2016) The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget 7:61021\u201361035","journal-title":"Oncotarget"},{"key":"4278_CR184","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1152\/ajpgi.00263.2012","volume":"304","author":"W Cao","year":"2013","unstructured":"Cao W, Tian W, Hong J, Li D, Tavares R, Noble L, Moss SF, Resnick MB (2013) Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Physiol Gastrointest Liver Physiol 304:322\u2013327","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR185","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3892\/mmr.2014.3004","volume":"11","author":"HB Yang","year":"2015","unstructured":"Yang HB, Song W, Cheng MD, Fan HF, Gu X, Qiao Y, Lu X, Yu RH, Chen LY (2015) Deoxycholic acid inhibits the growth of BGC-823 gastric carcinoma cells via a p53-mediated pathway. Mol Med Rep 11:2749\u20132754","journal-title":"Mol Med Rep"},{"key":"4278_CR186","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s12010-013-0417-6","volume":"171","author":"W Song","year":"2013","unstructured":"Song W, Yang HB, Chen P, Wang SM, Zhao LP, Xu WH, Fan HF, Gu X, Chen LY (2013) Apoptosis of human gastric carcinoma SGC-7901 induced by deoxycholic acid via the mitochondrial-dependent pathway. Appl Biochem Biotechnol 171:1061\u20131071","journal-title":"Appl Biochem Biotechnol"},{"key":"4278_CR187","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fphar.2015.00287","volume":"6","author":"C Guo","year":"2015","unstructured":"Guo C, Qi H, Yu Y, Zhang Q, Su J, Yu D, Huang W, Chen WD, Wang YD (2015) The G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits gastric inflammation through antagonizing NF-\u03baB signaling pathway. Front Pharmacol 6:287","journal-title":"Front Pharmacol"},{"key":"4278_CR188","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1111\/j.1349-7006.2008.00898.x","volume":"99","author":"K Fukase","year":"2008","unstructured":"Fukase K, Ohtsuka H, Onogawa T, Oshio H, Ii T, Mutoh M, Katayose Y, Rikiyama T, Oikawa M, Motoi F, Egawa S, Abe T, Unno M (2008) Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. Cancer Sci 99:1785\u20131792","journal-title":"Cancer Sci"},{"key":"4278_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19071898","volume":"19","author":"M Kainuma","year":"2018","unstructured":"Kainuma M, Takada I, Makishima M, Sano K (2018) Farnesoid X receptor activation enhances transforming growth factor \u03b2-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells. Int J Mol Sci 19:1\u20139","journal-title":"Int J Mol Sci"},{"key":"4278_CR190","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1158\/1541-7786.MCR-14-0230","volume":"13","author":"Y Hu","year":"2015","unstructured":"Hu Y, Chau T, Liu HX, Liao D, Keane R, Nie Y, Yang H, Wan YJY (2015) Bile acids regulate nuclear receptor (Nur77) expression and intracellular location to control proliferation and apoptosis. Mol Cancer Res 13:281\u2013292","journal-title":"Mol Cancer Res"},{"key":"4278_CR191","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00432-013-1554-6","volume":"140","author":"ES Jang","year":"2014","unstructured":"Jang ES, Yoon JH, Lee SH, Lee SM, Lee JH, Yu SJ, Kim YJ, Lee HS, Kim CY (2014) Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: Enhanced apoptosis versus growth stimulation. J Cancer Res Clin Oncol 140:133\u2013144","journal-title":"J Cancer Res Clin Oncol"},{"key":"4278_CR192","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00432-020-03374-9","volume":"146","author":"PT Nguyen","year":"2020","unstructured":"Nguyen PT, Kanno K, Pham QT, Kikuchi Y, Kakimoto M, Kobayashi T, Otani Y, Kishikawa N, Miyauchi M, Arihiro K, Ito M, Tazuma S (2020) Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma. J Cancer Res Clin Oncol 146:3255\u20133268","journal-title":"J Cancer Res Clin Oncol"},{"key":"4278_CR193","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.cellsig.2012.04.015","volume":"24","author":"Z Xu","year":"2012","unstructured":"Xu Z, Huang G, Gong W, Zhou P, Zhao Y, Zhang Y, Zeng Y, Gao M, Pan Z, He F (2012) FXR ligands protect against hepatocellular inflammation via SOCS3 induction. Cell Signal 24:1658\u20131664","journal-title":"Cell Signal"},{"key":"4278_CR194","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbrc.2013.03.058","volume":"434","author":"C Langhi","year":"2013","unstructured":"Langhi C, Pedraz-Cuesta E, Donate Y, Marrero PF, Haro D, Rodr\u00edguez JC (2013) Regulation of N-Myc downstream regulated gene 2 by bile acids. Biochem Biophys Res Commun 434:102\u2013109","journal-title":"Biochem Biophys Res Commun"},{"key":"4278_CR195","first-page":"2551","volume":"42","author":"S Lee","year":"2018","unstructured":"Lee S, Cho YY, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ (2018) Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK, Internaltion. J Mol Med 42:2551\u20132559","journal-title":"J Mol Med"},{"key":"4278_CR196","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3748\/wjg.v13.i11.1652","volume":"13","author":"H Liu","year":"2007","unstructured":"Liu H, Qin CY, Han GQ, Xu HW, Meng M, Yang Z (2007) Mechanism of apoptotic effects induced selectively by ursodeoxycholic acid on human hepatoma cell lines. World J Gastroenterol 13:1652\u20131658","journal-title":"World J Gastroenterol"},{"key":"4278_CR197","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/1751-2980.12191","volume":"15","author":"L Zhu","year":"2014","unstructured":"Zhu L, Shan LJ, Liu YJ, Chen D, Xiao XG, Li Y (2014) Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro. J Dig Dis 15:684\u2013693","journal-title":"J Dig Dis"},{"key":"4278_CR198","first-page":"1739","volume":"25","author":"GE Chung","year":"2011","unstructured":"Chung GE, Yoon JH, Lee JH, Kim HY, Myung SJ, Yu SJ, Lee SH, Lee SM, Kim YJ, Lee HS (2011) Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth. Oncol Rep 25:1739\u20131746","journal-title":"Oncol Rep"},{"key":"4278_CR199","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/ijc.24853","volume":"126","author":"SC Lim","year":"2010","unstructured":"Lim SC, Choi JE, Kang HS, Si H (2010) Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. Int J Cancer 126:1582\u20131595","journal-title":"Int J Cancer"},{"key":"4278_CR200","doi-asserted-by":"publisher","first-page":"e63435","DOI":"10.1371\/journal.pone.0063435","volume":"8","author":"CS Yang","year":"2013","unstructured":"Yang CS, Yuk JM, Kim JJ, Hwang JH, Lee CH, Kim JM, Oh GT, Choi HS, Jo EK (2013) Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2. PLoS ONE 8:e63435","journal-title":"PLoS ONE"},{"key":"4278_CR201","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1478-3231.2005.01033.x","volume":"25","author":"G Zollner","year":"2005","unstructured":"Zollner G, Wagner M, Fickert P, Silbert D, Fuchsbichler A, Zatloukal K, Denk H, Trauner M (2005) Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int 25:367\u2013379","journal-title":"Liver Int"},{"key":"4278_CR202","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","volume":"58","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic E, Claudel T, Trauner M (2013) Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol 58:155\u2013168","journal-title":"J Hepatol"},{"key":"4278_CR203","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","volume":"65","author":"JP Arab","year":"2017","unstructured":"Arab JP, Karpen SJ, Dawson PA, Arrese M, Trauner M (2017) Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives. Hepatology 65:350\u2013362","journal-title":"Hepatology"},{"key":"4278_CR204","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.1038\/srep08984","volume":"5","author":"W Zhang","year":"2015","unstructured":"Zhang W, Zhou L, Yin P, Wang J, Lu X, Wang X, Chen J, Lin X, Xu G (2015) A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma. Sci Rep 5:8984","journal-title":"Sci Rep"},{"key":"4278_CR205","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep.21287","volume":"44","author":"AS Knisely","year":"2006","unstructured":"Knisely AS, Strautnieks SS, Meier Y, Stieger B, Byrne JA, Portmann BC, Bull LN, Pawlikowska L, Bilezik\u00e7i B, Oz\u00e7ay F, L\u00e1szl\u00f3 A, Tiszlavicz L, Moore L, Raftos J, Arnell H, Fischler B, N\u00e9meth A, Papadogiannakis N, Cielecka-Kuszyk J, Jankowska I, Paw\u0142owska J, Mel\u00edn-Aldana H, Emerick KM, Whitington PF, Mieli-Vergani G, Thompson RJ (2006) Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 44:478\u2013486","journal-title":"Hepatology"},{"key":"4278_CR206","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","volume":"67","author":"F Yang","year":"2007","unstructured":"Yang F, Huang X, Yi T, Yen Y, Moore DD, Huang W (2007) Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Can Res 67:863\u2013867","journal-title":"Can Res"},{"key":"4278_CR207","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/hep.27274","volume":"61","author":"C Degirolamo","year":"2015","unstructured":"Degirolamo C, Modica S, Vacca M, Di Tullio G, Morgano A, D\u2019Orazio A, Kannisto K, Parini P, Moschetta A (2015) Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation. Hepatology 61:161\u2013170","journal-title":"Hepatology"},{"key":"4278_CR208","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/jpet.111.179390","volume":"338","author":"A Wolfe","year":"2011","unstructured":"Wolfe A, Thomas A, Edwards G, Jaseja R, Guo GL, Apte U (2011) Increased activation of the Wnt\/\u03b2-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice. J Pharmacol Exp Ther 338:12\u201321","journal-title":"J Pharmacol Exp Ther"},{"key":"4278_CR209","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1248\/bpb.32.172","volume":"32","author":"M Nomoto","year":"2009","unstructured":"Nomoto M, Miyata M, Yin S, Kurata Y, Shimada M, Yoshinari K, Gonzalez FJ, Suzuki K, Shibasaki S, Kurosawa T, Yamazoe Y (2009) Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor. Biol Pharm Bull 32:172\u2013178","journal-title":"Biol Pharm Bull"},{"key":"4278_CR210","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1089\/ars.2020.8024","volume":"33","author":"K Smolkov\u00e1","year":"2020","unstructured":"Smolkov\u00e1 K, Mik\u00f3 E, Kov\u00e1cs T, Leguina-Ruzzi A, Sipos A, Bai P (2020) NRF2 in regulating cancer metabolism. Antioxid Redox Signal 33:966\u2013997","journal-title":"Antioxid Redox Signal"},{"key":"4278_CR211","doi-asserted-by":"publisher","first-page":"G295","DOI":"10.1152\/ajpgi.00134.2015","volume":"310","author":"B Kong","year":"2016","unstructured":"Kong B, Zhu Y, Li G, Williams JA, Buckley K, Tawfik O, Luyendyk JP, Guo GL (2016) Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis. Am J Physiol Gastrointestinal and Liver Physiology 310:G295-302","journal-title":"Am J Physiol Gastrointestinal and Liver Physiology"},{"key":"4278_CR212","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W (2018) Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol 15:111\u2013128","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4278_CR213","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mrrev.2004.08.001","volume":"589","author":"H Bernstein","year":"2005","unstructured":"Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H (2005) Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 589:47\u201365","journal-title":"Mutat Res"},{"key":"4278_CR214","first-page":"851","volume":"2011","author":"RM Gadaleta","year":"1812","unstructured":"Gadaleta RM, Oldenburg B, Willemsen EC, Spit M, Murzilli S, Salvatore L, Klomp LW, Siersema PD, van Erpecum KJ, van Mil SW (1812) Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-\u03baB signaling in the intestine. Biochem Biophys Acta 2011:851\u2013858","journal-title":"Biochem Biophys Acta"},{"key":"4278_CR215","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.22342","volume":"48","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Xu P, Park K, Choi Y, Moore DD, Wang L (2008) Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation. Hepatology 48:289\u2013298","journal-title":"Hepatology"},{"key":"4278_CR216","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1128\/MCB.01076-09","volume":"30","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Soto J, Park K, Viswanath G, Kuwada S, Abel ED, Wang L (2010) Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth. Mol Cell Biol 30:1341\u20131356","journal-title":"Mol Cell Biol"},{"key":"4278_CR217","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1053\/j.gastro.2008.01.006","volume":"134","author":"N He","year":"2008","unstructured":"He N, Park K, Zhang Y, Huang J, Lu S, Wang L (2008) Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth. Gastroenterology 134:793\u2013802","journal-title":"Gastroenterology"},{"key":"4278_CR218","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1038\/ncomms7115","volume":"6","author":"CS Yang","year":"2015","unstructured":"Yang CS, Kim JJ, Kim TS, Lee PY, Kim SY, Lee HM, Shin DM, Nguyen LT, Lee MS, Jin HS, Kim KK, Lee CH, Kim MH, Park SG, Kim JM, Choi HS, Jo EK (2015) Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome. Nat Communun 6:6115","journal-title":"Nat Communun"},{"key":"4278_CR219","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.clinimag.2019.11.015","volume":"60","author":"D Gandhi","year":"2020","unstructured":"Gandhi D, Ojili V, Nepal P, Nagar A, Hernandez-Delima FJ, Bajaj D, Choudhary G, Gupta N, Sharma P (2020) A pictorial review of gall stones and its associated complications. Clin Imaging 60:228\u2013236","journal-title":"Clin Imaging"},{"key":"4278_CR220","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.3748\/wjg.v22.i33.7463","volume":"22","author":"HY Feng","year":"2016","unstructured":"Feng HY, Chen YC (2016) Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective. World J Gastroenterol 22:7463\u20137477","journal-title":"World J Gastroenterol"},{"key":"4278_CR221","doi-asserted-by":"publisher","first-page":"e15708","DOI":"10.1097\/MD.0000000000015708","volume":"98","author":"H Fu","year":"2019","unstructured":"Fu H, Li Y, Bai G, Yin R, Yin C, Shi W, Zhang L, Li R, Zhao R (2019) Persistent cholestasis resulting from duodenal papillary carcinoma in an adolescent male: A case report. Medicine 98:e15708","journal-title":"Medicine"},{"key":"4278_CR222","first-page":"53","volume":"17","author":"RM Thomas","year":"2020","unstructured":"Thomas RM, Jobin C (2020) Microbiota in pancreatic health and disease: the next frontier in microbiome research, Nature Reviews. Gastroenterol Hepatol 17:53\u201364","journal-title":"Gastroenterol Hepatol"},{"key":"4278_CR223","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jsbmb.2017.10.011","volume":"174","author":"DO Rees","year":"2017","unstructured":"Rees DO, Crick PJ, Jenkins GJ, Wang Y, Griffiths WJ, Brown TH, Al-Sarireh B (2017) Comparison of the composition of bile acids in bile of patients with adenocarcinoma of the pancreas and benign disease. J Steroid Biochem Mol Biol 174:290\u2013295","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4278_CR224","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jss.2006.04.025","volume":"136","author":"T Adachi","year":"2006","unstructured":"Adachi T, Tajima Y, Kuroki T, Mishima T, Kitasato A, Fukuda K, Tsutsumi R, Kanematsu T (2006) Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters. J Surg Res 136:106\u2013111","journal-title":"J Surg Res"},{"key":"4278_CR225","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/carcin\/bgh010","volume":"25","author":"ON Tucker","year":"2004","unstructured":"Tucker ON, Dannenberg AJ, Yang EY, Fahey Iii TJ (2004) Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis 25:419\u2013423","journal-title":"Carcinogenesis"},{"key":"4278_CR226","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-13-2329","volume":"74","author":"NS Nagathihalli","year":"2014","unstructured":"Nagathihalli NS, Beesetty Y, Lee W, Washington MK, Chen X, Lockhart AC, Merchant NB (2014) Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-\u03b1: impact on gastrointestinal cancers driven by secondary bile acids. Can Res 74:2062\u20132072","journal-title":"Can Res"},{"key":"4278_CR227","first-page":"3632","volume":"38","author":"YJ Kim","year":"2017","unstructured":"Kim YJ, Jeong SH, Kim EK, Kim EJ, Cho JH (2017) Ursodeoxycholic acid suppresses epithelial-mesenchymal transition and cancer stem cell formation by reducing the levels of peroxiredoxin II and reactive oxygen species in pancreatic cancer cells. Oncol Rep 38:3632\u20133638","journal-title":"Oncol Rep"},{"key":"4278_CR228","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/1097-0142(197706)39:6<2533::AID-CNCR2820390634>3.0.CO;2-X","volume":"39","author":"BS Reddy","year":"1977","unstructured":"Reddy BS, Wynder EL (1977) Metabolic epidemiology of colon cancer Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer 39:2533\u20132539","journal-title":"Cancer"},{"key":"4278_CR229","doi-asserted-by":"publisher","first-page":"H216","DOI":"10.1111\/1750-3841.13166","volume":"81","author":"Y Murakami","year":"2016","unstructured":"Murakami Y, Tanabe S, Suzuki T (2016) High-fat diet-induced intestinal hyperpermeability is associated with increased bile acids in the large intestine of mice. J Food Sci 81:H216-222","journal-title":"J Food Sci"},{"key":"4278_CR230","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1053\/gast.2001.27083","volume":"121","author":"J Lagergren","year":"2001","unstructured":"Lagergren J, Ye W, Ekbom A (2001) Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 121:542\u2013547","journal-title":"Gastroenterology"},{"key":"4278_CR231","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/CEG.S4343","volume":"1","author":"CM Payne","year":"2008","unstructured":"Payne CM, Bernstein C, Dvorak K, Bernstein H (2008) Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol 1:19\u201347","journal-title":"Clin Exp Gastroenterol"},{"key":"4278_CR232","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.molmed.2011.05.010","volume":"17","author":"C Degirolamo","year":"2011","unstructured":"Degirolamo C, Modica S, Palasciano G, Moschetta A (2011) Bile acids and colon cancer: solving the puzzle with nuclear receptors. Trends Mol Med 17:564\u2013572","journal-title":"Trends Mol Med"},{"key":"4278_CR233","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/01.sla.0000236631.72698.99","volume":"245","author":"DJ Turner","year":"2007","unstructured":"Turner DJ, Alaish SM, Zou T, Rao JN, Wang JY, Strauch ED (2007) Bile salts induce resistance to apoptosis through NF-kappaB-mediated XIAP expression. Ann Surg 245:415\u2013425","journal-title":"Ann Surg"},{"key":"4278_CR234","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/19490976.2016.1150414","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Wolf PG, Gaskins HR (2016) Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes 7:201\u2013215","journal-title":"Gut Microbes"},{"key":"4278_CR235","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijc.2910520319","volume":"52","author":"XP Huang","year":"1992","unstructured":"Huang XP, Fan XT, Desjeux JF, Castagna M (1992) Bile acids, non-phorbol-ester-type tumor promoters, stimulate the phosphorylation of protein kinase C substrates in human platelets and colon cell line HT29. Int J Cancer 52:444\u2013450","journal-title":"Int J Cancer"},{"key":"4278_CR236","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1023\/A:1023712712025","volume":"48","author":"A Moschetta","year":"2003","unstructured":"Moschetta A, Portincasa P, van Erpecum KJ, Debellis L, Vanberge-Henegouwen GP, Palasciano G (2003) Sphingomyelin protects against apoptosis and hyperproliferation induced by deoxycholate: potential implications for colon cancer. Dig Dis Sci 48:1094\u20131101","journal-title":"Dig Dis Sci"},{"key":"4278_CR237","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2174\/187152008784533008","volume":"8","author":"A Zimber","year":"2008","unstructured":"Zimber A, Gespach C (2008) Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential. Anticancer Agents Med Chem 8:540\u2013563","journal-title":"Anticancer Agents Med Chem"},{"key":"4278_CR238","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13287-016-0439-4","volume":"7","author":"L Farhana","year":"2016","unstructured":"Farhana L, Nangia-Makker P, Arbit E, Shango K, Sarkar S, Mahmud H, Hadden T, Yu Y, Majumdar AP (2016) Bile acid: a potential inducer of colon cancer stem cells. Stem Cell Res Ther 7:181","journal-title":"Stem Cell Res Ther"},{"key":"4278_CR239","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0304-3835(97)00452-7","volume":"124","author":"T Hori","year":"1998","unstructured":"Hori T, Matsumoto K, Sakaitani Y, Sato M, Morotomi M (1998) Effect of dietary deoxycholic acid and cholesterol on fecal steroid concentration and its impact on the colonic crypt cell proliferation in azoxymethane-treated rats. Cancer Lett 124:79\u201384","journal-title":"Cancer Lett"},{"key":"4278_CR240","doi-asserted-by":"publisher","first-page":"s4","DOI":"10.5604\/5601.3001.0010.5493","volume":"16","author":"A Di Ciaula","year":"2017","unstructured":"Di Ciaula A, Garruti G, Lunardi Baccetto R, Molina-Molina E, Bonfrate L, Wang DQ, Portincasa P (2017) Bile acid physiology. Ann Hepatol 16:s4\u2013s14. https:\/\/doi.org\/10.5604\/5601.3001.0010.5493","journal-title":"Ann Hepatol"},{"key":"4278_CR241","doi-asserted-by":"publisher","first-page":"s87","DOI":"10.5604\/01.3001.0010.5501","volume":"16","author":"A Di Ciaula","year":"2017","unstructured":"Di Ciaula A, Wang DQ, Molina-Molina E, Lunardi Baccetto R, Calamita G, Palmieri VO, Portincasa P (2017) Bile acids and cancer: direct and environmental-dependent effects. Ann Hepatol 16:s87\u2013s105","journal-title":"Ann Hepatol"},{"key":"4278_CR242","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jnutbio.2015.04.007","volume":"26","author":"H Zeng","year":"2015","unstructured":"Zeng H, Claycombe KJ, Reindl KM (2015) Butyrate and deoxycholic acid play common and distinct roles in HCT116 human colon cell proliferation. J Nutr Biochem 26:1022\u20131028","journal-title":"J Nutr Biochem"},{"key":"4278_CR243","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1158\/1055-9965.861.13.5","volume":"13","author":"LM Hess","year":"2004","unstructured":"Hess LM, Krutzsch MF, Guillen J, Chow HH, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS (2004) Results of a phase I multiple-dose clinical study of ursodeoxycholic acid. Cancer Epidemiol Biomark Prev 13:861\u2013867","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4278_CR244","first-page":"1","volume":"12","author":"EK Kim","year":"2017","unstructured":"Kim EK, Cho JH, Kim EJ, Kim YJ (2017) Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth. PLoS ONE 12:1\u201311","journal-title":"PLoS ONE"},{"key":"4278_CR245","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000075927","volume":"68","author":"T Ochsenkuhn","year":"2003","unstructured":"Ochsenkuhn T, Marsteller I, Hay U, Diebold J, Paumgartner G, Goke B, Sackmann M (2003) Does ursodeoxycholic acid change the proliferation of the colorectal mucosa? A randomized, placebo-controlled study. Digestion 68:209\u2013216","journal-title":"Digestion"},{"key":"4278_CR246","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jn\/134.2.483","volume":"2","author":"E Im","year":"2004","unstructured":"Im E, Martinez JD (2004) Diet induced changes in the colonic environment and colorectal cancer ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR\/ Raf-1\/ERK signaling in human colon cancer cells. J Nutr 2:483\u2013486","journal-title":"J Nutr"},{"key":"4278_CR247","first-page":"319","volume":"83","author":"B Rigas","year":"1994","unstructured":"Rigas B, Tsioulias GJ, Allan C, Wali RK, Brasitus TA (1994) The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development. Immunology 83:319\u2013323","journal-title":"Immunology"},{"key":"4278_CR248","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/jnci\/dji144","volume":"97","author":"DS Alberts","year":"2005","unstructured":"Alberts DS, Martinez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P (2005) Gastroenterologist, Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97:846\u2013853","journal-title":"J Natl Cancer Inst"},{"key":"4278_CR249","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","volume":"134","author":"BY Tung","year":"2001","unstructured":"Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA (2001) Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 134:89\u201395","journal-title":"Ann Intern Med"},{"key":"4278_CR250","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/jhep.2003.50311","volume":"38","author":"L Serfaty","year":"2003","unstructured":"Serfaty L, De Leusse A, Rosmorduc O, Desaint B, Flejou JF, Chazouilleres O, Poupon RE, Poupon R (2003) Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Hepatology 38:203\u2013209","journal-title":"Hepatology"},{"key":"4278_CR251","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett WS (2015) Cancer and the microbiota. Science 348:80\u201386","journal-title":"Science"},{"key":"4278_CR252","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrmicro2819","volume":"10","author":"H Tjalsma","year":"2012","unstructured":"Tjalsma H, Boleij A, Marchesi JR, Dutilh BE (2012) A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10:575\u2013582","journal-title":"Nat Rev Microbiol"},{"key":"4278_CR253","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.7150\/jca.20497","volume":"8","author":"H Raskov","year":"2017","unstructured":"Raskov H, Burcharth J, Pommergaard HC (2017) Linking gut microbiota to colorectal cancer. J Cancer 8:3378\u20133395","journal-title":"J Cancer"},{"key":"4278_CR254","doi-asserted-by":"publisher","first-page":"G550","DOI":"10.1152\/ajpgi.00256.2016","volume":"312","author":"JBJ Ward","year":"2017","unstructured":"Ward JBJ, Lajczak NK, Kelly OB, O\u2019Dwyer AM, Giddam AK, Ni Gabhann J, Franco P, Tambuwala MM, Jefferies CA, Keely S, Roda A, Keely SJ (2017) Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am J Physiol Gastrointest Liver Physiol 312:G550\u2013G558","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR255","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","volume":"141","author":"KB Islam","year":"2011","unstructured":"Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A (2011) Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141:1773\u20131781","journal-title":"Gastroenterology"},{"key":"4278_CR256","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature11225","volume":"487","author":"S Devkota","year":"2012","unstructured":"Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice. Nature 487:104\u2013108","journal-title":"Nature"},{"key":"4278_CR257","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(94)92635-2","volume":"343","author":"NB Javitt","year":"1994","unstructured":"Javitt NB, Budai K, Miller DG, Cahan AC, Raju U, Levitz M (1994) Breast-gut connection: origin of chenodeoxycholic acid in breast cyst fluid. Lancet 343:633\u2013635","journal-title":"Lancet"},{"key":"4278_CR258","first-page":"1078","volume":"11","author":"W Tang","year":"2019","unstructured":"Tang W, Putluri V, Ambati CR, Dorsey TH, Putluri N, Ambs S (2019) Liver- and microbiome-derived bile acids accumulate in human breast tumors and inhibit growth and improve patient survival. Clin Cancer Res 11:1078\u20131432","journal-title":"Clin Cancer Res"},{"key":"4278_CR259","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/bjc.1980.333","volume":"42","author":"WR Murray","year":"1980","unstructured":"Murray WR, Blackwood A, Calman KC, MacKay C (1980) Faecal bile acids and clostridia in patients with breast cancer. Br J Cancer 42:856\u2013860","journal-title":"Br J Cancer"},{"key":"4278_CR260","doi-asserted-by":"publisher","first-page":"108914","DOI":"10.1016\/j.steroids.2021.108914","volume":"175","author":"C Luo","year":"2021","unstructured":"Luo C, Zhang X, He Y, Chen H, Liu M, Wang H, Tang L, Tu G, Ding M (2021) A pseudo-targeted metabolomics study based on serum bile acids profiling for the differential diagnosis of benign and malignant breast lesions. Steroids 175:108914","journal-title":"Steroids"},{"key":"4278_CR261","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1210\/jcem-70-4-1030","volume":"70","author":"U Raju","year":"1990","unstructured":"Raju U, Levitz M, Javitt NB (1990) Bile acids in human breast cyst fluid: the identification of lithocholic acid. J Clin Endocrinol Metab 70:1030\u20131034","journal-title":"J Clin Endocrinol Metab"},{"key":"4278_CR262","first-page":"305","volume":"156","author":"V Costarelli","year":"2002","unstructured":"Costarelli V, Sanders TA (2002) Plasma bile acids and risk of breast cancer. IARC Sci Publ 156:305\u2013306","journal-title":"IARC Sci Publ"},{"key":"4278_CR263","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/sj.ejcn.1601396","volume":"56","author":"V Costarelli","year":"2002","unstructured":"Costarelli V, Sanders TA (2002) Plasma deoxycholic acid concentration is elevated in postmenopausal women with newly diagnosed breast cancer. Eur J Clin Nutr 56:925\u2013927","journal-title":"Eur J Clin Nutr"},{"key":"4278_CR264","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s13058-014-0415-9","volume":"16","author":"X Tang","year":"2014","unstructured":"Tang X, Lin CC, Spasojevic I, Iversen ES, Chi JT, Marks JR (2014) A joint analysis of metabolomics and genetics of breast cancer. Breast Cancer Res 16:415","journal-title":"Breast Cancer Res"},{"key":"4278_CR265","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1158\/0008-5472.CAN-06-2399","volume":"66","author":"KE Swales","year":"2006","unstructured":"Swales KE, Korbonits M, Carpenter R, Walsh DT, Warner TD, Bishop-Bailey D (2006) The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Can Res 66:10120\u201310126","journal-title":"Can Res"},{"key":"4278_CR266","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10555-021-10013-3","volume":"40","author":"T Kov\u00e1cs","year":"2022","unstructured":"Kov\u00e1cs T, Mik\u00f3 E, Ujlaki G, Yousef H, Csontos V, Uray K, Bai P (2022) The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer Metastasis Rev 40:1223\u20131249","journal-title":"Cancer Metastasis Rev"},{"key":"4278_CR267","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/bjc.1992.115","volume":"65","author":"PR Baker","year":"1992","unstructured":"Baker PR, Wilton JC, Jones CE, Stenzel DJ, Watson N, Smith GJ (1992) Bile acids influence the growth, oestrogen receptor and oestrogen-regulated proteins of MCF-7 human breast cancer cells. Br J Cancer 65:566\u2013572","journal-title":"Br J Cancer"},{"key":"4278_CR268","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1038\/onc.2011.124","volume":"30","author":"C Giordano","year":"2011","unstructured":"Giordano C, Catalano S, Panza S, Vizza D, Barone I, Bonofiglio D, Gelsomino L, Rizza P, Fuqua SAW, And\u00f2 S (2011) Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression. Oncogene 30:4129\u20134140","journal-title":"Oncogene"},{"key":"4278_CR269","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10549-008-0094-2","volume":"115","author":"F Journe","year":"2009","unstructured":"Journe F, Durbecq V, Chaboteaux C, Rouas G, Laurent G, Nonclercq D, Sotiriou C, Body JJ, Larsimont D (2009) Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients. Breast Cancer Res Treat 115:523\u2013535","journal-title":"Breast Cancer Res Treat"},{"key":"4278_CR270","first-page":"5118","volume":"8","author":"N Liu","year":"2016","unstructured":"Liu N, Zhao J, Wang J, Teng H, Fu Y, Yuan H (2016) Farnesoid X receptor ligand CDCA suppresses human prostate cancer cells growth by inhibiting lipid metabolism via targeting sterol response element binding protein, American Journal of. Transl Res 8:5118\u20135124","journal-title":"Transl Res"},{"key":"4278_CR271","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3892\/etm.2014.1894","volume":"8","author":"J Liu","year":"2014","unstructured":"Liu J, Tong SJ, Wang X, Qu LX (2014) Farnesoid X receptor inhibits LNcaP cell proliferation via the upregulation of PTEN. Exp Ther Med 8:1209\u20131212","journal-title":"Exp Ther Med"},{"key":"4278_CR272","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1042\/BJ20071136","volume":"410","author":"J Kaeding","year":"2008","unstructured":"Kaeding J, Bouchaert E, B\u00e9langer J, Caron P, Chouinard S, Verreault M, Larouche O, Pelletier G, Staels B, B\u00e9langer A, Barbier O (2008) Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells. Biochem J 410:245\u2013253","journal-title":"Biochem J"},{"key":"4278_CR273","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.7717\/peerj.122","volume":"1","author":"AA Goldberg","year":"2013","unstructured":"Goldberg AA, Titorenko VI, Beach A, Sanderson JT (2013) Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells. PeerJ 1:e122","journal-title":"PeerJ"},{"key":"4278_CR274","doi-asserted-by":"publisher","first-page":"16","DOI":"10.15430\/JCP.2017.22.1.16","volume":"22","author":"WS Lee","year":"2017","unstructured":"Lee WS, Jung JH, Panchanathan R, Yun JW, Kim DH, Kim HJ, Kim GS, Ryu CH, Shin SC, Hong SC, Choi YH, Jung J-M (2017) Ursodeoxycholic acid induces death receptor-mediated apoptosis in prostate cancer cells. j Cancer Prev 22:16\u201321","journal-title":"j Cancer Prev"},{"key":"4278_CR275","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.29010","volume":"136","author":"C Ke","year":"2015","unstructured":"Ke C, Hou Y, Zhang H, Fan L, Ge T, Guo B, Zhang F, Yang K, Wang J, Lou G, Li K (2015) Large-scale profiling of metabolic dysregulation in ovarian cancer. Int J Cancer 136:516\u2013526","journal-title":"Int J Cancer"},{"key":"4278_CR276","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.7150\/jca.15074","volume":"7","author":"L Fan","year":"2016","unstructured":"Fan L, Yin M, Ke C, Ge T, Zhang G, Zhang W, Zhou X, Lou G, Li K (2016) Use of plasma metabolomics to identify diagnostic biomarkers for early stage epithelial ovarian cancer. J Cancer 7:1265\u20131272","journal-title":"J Cancer"},{"key":"4278_CR277","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1158\/1055-9965.EPI-10-0126","volume":"19","author":"M Zhou","year":"2010","unstructured":"Zhou M, Guan W, Walker LD, Mezencev R, Benigno BB, Gray A, Fern\u00e1ndez FM, McDonald JF (2010) Rapid mass spectrometric metabolic profiling of blood sera detects ovarian cancer with high accuracy. Cancer Epidemiol Biomark Prev 19:2262\u20132271","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4278_CR278","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/1471-2105-10-259","volume":"10","author":"W Guan","year":"2009","unstructured":"Guan W, Zhou M, Hampton CY, Benigno BB, Walker LD, Gray A, McDonald JF, Fern\u00e1ndez FM (2009) Ovarian cancer detection from metabolomic liquid chromatography\/mass spectrometry data by support vector machines. BMC Bioinformatics 10:259","journal-title":"BMC Bioinformatics"},{"key":"4278_CR279","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ygyno.2007.07.072","volume":"107","author":"NS Horowitz","year":"2007","unstructured":"Horowitz NS, Hua J, Powell MA, Gibb RK, Mutch DG, Herzog TJ (2007) Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis. Gynecol Oncol 107:344\u2013349","journal-title":"Gynecol Oncol"},{"key":"4278_CR280","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0959-8049(00)00450-0","volume":"37","author":"H Schuldes","year":"2001","unstructured":"Schuldes H, Dolderer JH, Zimmer G, Knobloch J, Bickeb\u00f6ller R, Jonas D, Woodcock BG (2001) Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile salts. Eur J Cancer 37:660\u2013667","journal-title":"Eur J Cancer"},{"key":"4278_CR281","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/CEJ.0000000000000398","volume":"27","author":"Q Jin","year":"2018","unstructured":"Jin Q, Noel O, Nguyen M, Sam L, Gerhard GS (2018) Bile acids upregulate BRCA1 and downregulate estrogen receptor 1 gene expression in ovarian cancer cells. Eur J Cancer Prev 27:553\u2013556","journal-title":"Eur J Cancer Prev"},{"key":"4278_CR282","first-page":"2703","volume":"21","author":"MJ Pascual","year":"2001","unstructured":"Pascual MJ, Macias RI, Garcia-Del-Pozo J, Serrano MA, Marin JJ (2001) Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid. Anticancer Res 21:2703\u20132707","journal-title":"Anticancer Res"},{"key":"4278_CR283","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1757-2215-3-13","volume":"3","author":"JJ Rough","year":"2010","unstructured":"Rough JJ, Monroy MA, Yerrum S, Daly JM (2010) Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. J Ovar Res 3:13","journal-title":"J Ovar Res"},{"key":"4278_CR284","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ygyno.2009.09.034","volume":"116","author":"DR Scoles","year":"2010","unstructured":"Scoles DR, Xu X, Wang H, Tran H, Taylor-Harding B, Li A, Karlan BY (2010) Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein. Gynecol Oncol 116:109\u2013116","journal-title":"Gynecol Oncol"},{"key":"4278_CR285","doi-asserted-by":"publisher","first-page":"E1601","DOI":"10.3390\/cells8121601","volume":"8","author":"M Curtarello","year":"2019","unstructured":"Curtarello M, Tognon M, Venturoli C, Silic-Benussi M, Grassi A, Verza M, Minuzzo S, Pinazza M, Brillo V, Tosi G, Ferrazza R, Guella G, Iorio E, Godfroid A, Sounni NE, Amadori A, Indraccolo S (2019) Rewiring of lipid metabolism and storage in ovarian cancer cells after anti-VEGF therapy. Cells 8:E1601","journal-title":"Cells"},{"key":"4278_CR286","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3892\/ijo.2016.3611","volume":"49","author":"H Masuyama","year":"2016","unstructured":"Masuyama H, Nakamura K, Nobumoto E, Hiramatsu Y (2016) Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells. Int J Oncol 49:1211\u20131220","journal-title":"Int J Oncol"},{"key":"4278_CR287","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jsbmb.2016.11.020","volume":"167","author":"B Bandera Merchan","year":"2017","unstructured":"Bandera Merchan B, Morcillo S, Martin-Nu\u00f1ez G, Tinahones FJ, Mac\u00edas-Gonz\u00e1lez M (2017) The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences. J Steroid Biochem Mol Biol 167:203\u2013218","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4278_CR288","doi-asserted-by":"publisher","first-page":"E1285","DOI":"10.3390\/ijms17081285","volume":"17","author":"YF Hou","year":"2016","unstructured":"Hou YF, Gao SH, Wang P, Zhang HM, Liu LZ, Ye MX, Zhou GM, Zhang ZL, Li BY (2016) 1\u03b1,25(OH)2D3 suppresses the migration of ovarian cancer SKOV-3 cells through the inhibition of epithelial\u2013mesenchymal transition. Int J Mol Sci 17:E1285","journal-title":"Int J Mol Sci"},{"key":"4278_CR289","first-page":"3393","volume":"41","author":"M Ji","year":"2019","unstructured":"Ji M, Liu L, Hou Y, Li B (2019) 1\u03b1,25-Dihydroxyvitamin D3 restrains stem cell-like properties of ovarian cancer cells by enhancing vitamin D receptor and suppressing CD44. Oncol Rep 41:3393\u20133403","journal-title":"Oncol Rep"},{"key":"4278_CR290","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.gene.2018.07.070","volume":"677","author":"J Li","year":"2018","unstructured":"Li J, Li B, Jiang Q, Zhang Y, Liu A, Wang H, Zhang J, Qin Q, Hong Z, Li BA (2018) Do genetic polymorphisms of the vitamin D receptor contribute to breast\/ovarian cancer? A systematic review and network meta-analysis. Gene 677:211\u2013227","journal-title":"Gene"},{"key":"4278_CR291","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jsbmb.2014.11.005","volume":"148","author":"P Lungchukiet","year":"2015","unstructured":"Lungchukiet P, Sun Y, Kasiappan R, Quarni W, Nicosia SV, Zhang X, Bai W (2015) Suppression of epithelial ovarian cancer invasion into the omentum by 1\u03b1,25-dihydroxyvitamin D3 and its receptor. J Steroid Biochem Mol Biol 148:138\u2013147","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4278_CR292","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2010.06.008","volume":"119","author":"F Silvagno","year":"2010","unstructured":"Silvagno F, Poma CB, Realmuto C, Ravarino N, Ramella A, Santoro N, D\u2019Amelio P, Fuso L, Pescarmona G, Zola P (2010) Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer. Gynecol Oncol 119:121\u2013124","journal-title":"Gynecol Oncol"},{"key":"4278_CR293","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/sj.bjc.6605414","volume":"101","author":"S Tamez","year":"2009","unstructured":"Tamez S, Norizoe C, Ochiai K, Takahashi D, Shimojima A, Tsutsumi Y, Yanaihara N, Tanaka T, Okamoto A, Urashima M (2009) Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 101:1957\u20131960","journal-title":"Br J Cancer"},{"key":"4278_CR294","first-page":"351","volume":"32","author":"T Cordes","year":"2012","unstructured":"Cordes T, Hoellen F, Dittmer C, Salehin D, K\u00fcmmel S, Friedrich M, K\u00f6ster F, Becker S, Diedrich K, Thill M (2012) Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer. Anticancer Res 32:351\u2013357","journal-title":"Anticancer Res"},{"key":"4278_CR295","doi-asserted-by":"publisher","first-page":"e34443","DOI":"10.1371\/journal.pone.0034443","volume":"7","author":"RG Moore","year":"2012","unstructured":"Moore RG, Lange TS, Robinson K, Kim KK, Uzun A, Horan TC, Kawar N, Yano N, Chu SR, Mao Q, Brard L, DePaepe ME, Padbury JF, Arnold LA, Brodsky A, Shen TL, Singh RK (2012) Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model. PLoS ONE 7:e34443","journal-title":"PLoS ONE"},{"key":"4278_CR296","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00418-020-01894-6","volume":"154","author":"B Czogalla","year":"2020","unstructured":"Czogalla B, Deuster E, Liao Y, Mayr D, Schmoeckel E, Sattler C, Kolben T, Hester A, Furst S, Burges A, Mahner S, Jeschke U, Trillsch F (2020) Cytoplasmic VDR expression as an independent risk factor for ovarian cancer. Histochem Cell Biol 154:421\u2013429","journal-title":"Histochem Cell Biol"},{"key":"4278_CR297","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.bcp.2012.01.030","volume":"83","author":"Y Chen","year":"2012","unstructured":"Chen Y, Tang Y, Guo C, Wang J, Boral D, Nie D (2012) Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem Pharmacol 83:1112\u20131126","journal-title":"Biochem Pharmacol"},{"key":"4278_CR298","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bcp.2014.06.003","volume":"90","author":"Y Wang","year":"2014","unstructured":"Wang Y, Masuyama H, Nobumoto E, Zhang G, Hiramatsu Y (2014) The inhibition of constitutive androstane receptor-mediated pathway enhances the effects of anticancer agents in ovarian cancer cells. Biochem Pharmacol 90:356\u2013366","journal-title":"Biochem Pharmacol"},{"key":"4278_CR299","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1158\/1078-0432.CCR-08-1033","volume":"14","author":"D Gupta","year":"2008","unstructured":"Gupta D, Venkatesh M, Wang H, Kim S, Sinz M, Goldberg GL, Whitney K, Longley C, Mani S (2008) Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer. Clin Cancer Res 14:5332\u20135340","journal-title":"Clin Cancer Res"},{"key":"4278_CR300","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.plipres.2021.101117","volume":"84","author":"M Szanto","year":"2021","unstructured":"Szanto M, Gupte R, Kraus WL, Pacher P, Bai P (2021) PARPs in lipid metabolism and related diseases. Progr Lipid Res 84:101117","journal-title":"Progr Lipid Res"},{"key":"4278_CR301","doi-asserted-by":"publisher","first-page":"115736","DOI":"10.18632\/oncotarget.22803","volume":"8","author":"JP Phelan","year":"2017","unstructured":"Phelan JP, Reen FJ, Caparros-Martin JA, O\u2019Connor R, O\u2019Gara F (2017) Rethinking the bile acid\/gut microbiome axis in cancer. Oncotarget 8:115736\u2013115747","journal-title":"Oncotarget"},{"key":"4278_CR302","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.R900011-JLR200","volume":"50","author":"JD Amaral","year":"2009","unstructured":"Amaral JD, Viana RJS, Ramalho RM, Steer CJ, Rodrigues CMP (2009) Bile acids: Regulation of apoptosis by ursodeoxycholic acid. J Lipid Res 50:1721\u20131734","journal-title":"J Lipid Res"},{"key":"4278_CR303","doi-asserted-by":"publisher","first-page":"e22094","DOI":"10.1371\/journal.pone.0022094","volume":"6","author":"J Trottier","year":"2011","unstructured":"Trottier J, Bia\u0142ek A, Caron P, Straka RJ, Milkiewicz P, Barbier O (2011) Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS ONE 6:e22094","journal-title":"PLoS ONE"},{"key":"4278_CR304","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1194\/jlr.D028803","volume":"53","author":"JC Garc\u00eda-Ca\u00f1averas","year":"2012","unstructured":"Garc\u00eda-Ca\u00f1averas JC, Donato MT, Castell JV, Lahoz A (2012) Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method. J Lipid Res 53:2231\u20132241","journal-title":"J Lipid Res"},{"key":"4278_CR305","doi-asserted-by":"publisher","first-page":"e16717","DOI":"10.1097\/MD.0000000000016717","volume":"98","author":"Z Ma","year":"2019","unstructured":"Ma Z, Wang X, Yin P, Wu R, Zhou L, Xu G, Niu J (2019) Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury. Medicine (Baltimore) 98:e16717","journal-title":"Medicine (Baltimore)"},{"key":"4278_CR306","doi-asserted-by":"publisher","first-page":"708495","DOI":"10.3389\/fmed.2021.708495","volume":"8","author":"Z Sun","year":"2021","unstructured":"Sun Z, Huang C, Shi Y, Wang R, Fan J, Yu Y, Zhang Z, Zhu K, Li M, Ni Q, Chen Z, Zheng M, Yang Z (2021) Distinct bile acid profiles in patients with chronic hepatitis b virus infection reveal metabolic interplay between host, virus and gut microbiome. Front Med 8:708495","journal-title":"Front Med"},{"key":"4278_CR307","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/metabo11090612","volume":"11","author":"SC James","year":"2021","unstructured":"James SC, Fraser K, Young W, Heenan PE, Gearry RB, Keenan JI, Talley NJ, Joyce SA, McNabb WC, Roy NC (2021) Concentrations of fecal bile acids in participants with functional gut disorders and healthy controls. Metabolites 11:2","journal-title":"Metabolites"},{"key":"4278_CR308","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.3748\/wjg.v26.i45.7153","volume":"26","author":"W Wei","year":"2020","unstructured":"Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK (2020) Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 26:7153\u20137172","journal-title":"World J Gastroenterol"},{"key":"4278_CR309","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10620-019-05823-z","volume":"65","author":"I Sergeev","year":"2020","unstructured":"Sergeev I, Keren N, Naftali T, Konikoff FM (2020) Cholecystectomy and biliary sphincterotomy increase fecal bile loss and improve lipid profile in dyslipidemia. Dig Dis Sci 65:1223\u20131230","journal-title":"Dig Dis Sci"},{"key":"4278_CR310","doi-asserted-by":"publisher","first-page":"11601","DOI":"10.1038\/s41598-020-68393-5","volume":"10","author":"A Zhao","year":"2020","unstructured":"Zhao A, Wang S, Chen W, Zheng X, Huang F, Han X, Ge K, Rajani C, Huang Y, Yu H, Zhu J, Jia W (2020) Increased levels of conjugated bile acids are associated with human bile reflux gastritis. Sci Rep 10:11601","journal-title":"Sci Rep"},{"key":"4278_CR311","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1007\/s00216-014-8230-9","volume":"406","author":"SE J\u00e4ntti","year":"2014","unstructured":"J\u00e4ntti SE, Kivilompolo M, Ohrnberg L, Pietil\u00e4inen KH, Nygren H, Ore\u0161i\u010d M, Hy\u00f6tyl\u00e4inen T (2014) Quantitative profiling of bile acids in blood, adipose tissue, intestine, and gall bladder samples using ultra high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 406:7799\u20137815","journal-title":"Anal Bioanal Chem"},{"key":"4278_CR312","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0016-5085(97)70239-7","volume":"112","author":"KD Setchell","year":"1997","unstructured":"Setchell KD, Rodrigues CM, Clerici C, Solinas A, Morelli A, Gartung C, Boyer J (1997) Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology 112:226\u2013235","journal-title":"Gastroenterology"},{"key":"4278_CR313","first-page":"61","volume":"30","author":"A Honda","year":"1995","unstructured":"Honda A, Yoshida T, Tanaka N, Matsuzaki Y, He B, Shoda J, Osuga T (1995) Increased bile acid concentration in liver tissue with cholesterol gallstone disease. J Gastroenterol Hepatol 30:61\u201366","journal-title":"J Gastroenterol Hepatol"},{"key":"4278_CR314","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1021\/acschemneuro.0c00095","volume":"11","author":"Z Yao","year":"2020","unstructured":"Yao Z, Zhang X, Zhao F, Wang S, Chen A, Huang B, Wang J, Li X (2020) Ursodeoxycholic acid inhibits glioblastoma progression via endoplasmic reticulum stress related apoptosis and synergizes with the proteasome inhibitor bortezomib. ACS Chem Neurosci 11:1337\u20131346","journal-title":"ACS Chem Neurosci"},{"key":"4278_CR315","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1007\/s12035-016-0145-3","volume":"54","author":"I Fonseca","year":"2017","unstructured":"Fonseca I, Gordino G, Moreira S, Nunes MJ, Azevedo C, Gama MJ, Rodrigues E, Rodrigues CMP, Castro-Caldas M (2017) Tauroursodeoxycholic acid protects against mitochondrial dysfunction and cell death via mitophagy in human neuroblastoma cells. Mol Neurobiol 54:6107\u20136119","journal-title":"Mol Neurobiol"},{"key":"4278_CR316","first-page":"213","volume":"41","author":"H Yu","year":"2019","unstructured":"Yu H, Fu QR, Huang ZJ, Lin JY, Chen QX, Wang Q, Shen DY (2019) Apoptosis induced by ursodeoxycholic acid in human melanoma cells through the mitochondrial pathway. Oncol Rep 41:213\u2013223","journal-title":"Oncol Rep"},{"key":"4278_CR317","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.3748\/wjg.v21.i36.10367","volume":"21","author":"H Liu","year":"2015","unstructured":"Liu H, Xu HW, Zhang YZ, Huang Y, Han GQ, Liang TJ, Wei LL, Qin CY, Qin CK (2015) Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice. World J Gastroenterol 21:10367\u201310374","journal-title":"World J Gastroenterol"},{"key":"4278_CR318","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.3390\/nu7053200","volume":"7","author":"L Pang","year":"2015","unstructured":"Pang L, Zhao X, Liu W, Deng J, Tan X, Qiu L (2015) Anticancer effect of ursodeoxycholic acid in human oral squamous carcinoma HSC-3 cells through the caspases. Nutrients 7:3200\u20133218","journal-title":"Nutrients"},{"key":"4278_CR319","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1749-6632.2009.04710.x","volume":"1171","author":"C Fimognari","year":"2009","unstructured":"Fimognari C, Lenzi M, Cantelli-Forti G, Hrelia P (2009) Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells. Ann N Y Acad Sci 1171:264\u2013269","journal-title":"Ann N Y Acad Sci"},{"key":"4278_CR320","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-018-0569-0","volume":"18","author":"YC Wu","year":"2018","unstructured":"Wu YC, Chiu CF, Hsueh CT, Hsueh CT (2018) The role of bile acids in cellular invasiveness of gastric cancer. Cancer Cell Int 18:1\u20138","journal-title":"Cancer Cell Int"},{"key":"4278_CR321","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/carcin\/bgr038","volume":"32","author":"SC Lim","year":"2011","unstructured":"Lim SC, Duong HQ, Choi JE, Lee TB, Kang JH, Oh SH, Han SI (2011) Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis 32:723\u2013731","journal-title":"Carcinogenesis"},{"key":"4278_CR322","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3892\/or.2012.1918","volume":"28","author":"SC Lim","year":"2012","unstructured":"Lim SC, Duong HQ, Parajuli KR, Han SI (2012) Pro-apoptotic role of the MEK\/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells. Oncol Rep 28:1429\u20131434","journal-title":"Oncol Rep"},{"key":"4278_CR323","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3892\/or.2015.4076","volume":"34","author":"SC Lim","year":"2015","unstructured":"Lim SC, Han SI (2015) Ursodeoxycholic acid effectively kills drug-resistant gastric cancer cells through induction of autophagic death. Oncol Rep 34:1261\u20131268","journal-title":"Oncol Rep"},{"key":"4278_CR324","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1152\/ajpgi.00085.2014","volume":"307","author":"S Peng","year":"2014","unstructured":"Peng S, Huo X, Rezaei D, Zhang Q, Zhang X, Yu C, Asanuma K, Cheng E, Pham TH, Wang DH, Chen M, Souza RF, Spechler SJ (2014) In Barrett\u2019s esophagus patients and Barrett\u2019s cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids. Am J Physiol Gastrointest Liver Physiol 307:129\u2013139","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR325","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/CEJ.0000000000000198","volume":"25","author":"MM Abdel-Latif","year":"2016","unstructured":"Abdel-Latif MM, Inoue H, Reynolds JV (2016) Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells. Eur J Cancer Prev 25:368\u2013379","journal-title":"Eur J Cancer Prev"},{"key":"4278_CR326","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1442-2050.2009.00993.x","volume":"23","author":"A Goldman","year":"2010","unstructured":"Goldman A, Condon A, Adler E, Minnella M, Bernstein C, Bernstein H, Dvorak K (2010) Protective effects of glycoursodeoxycholic acid in Barrett\u2019s esophagus cells. Dis Esophagus 23:83\u201393","journal-title":"Dis Esophagus"},{"key":"4278_CR327","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1207\/s15327914nc5101_15","volume":"51","author":"E Im","year":"2005","unstructured":"Im E, Akare S, Powell A, Martinez JD (2005) Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt\/PKB-dependent survival signaling. Nutr Cancer 51:110\u2013116","journal-title":"Nutr Cancer"},{"key":"4278_CR328","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/01635581.2012.669876","volume":"64","author":"T Saeki","year":"2012","unstructured":"Saeki T, Yui S, Hirai T, Fujii T, Okada S, Kanamoto R (2012) Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation. Nutr Cancer 64:617\u2013626","journal-title":"Nutr Cancer"},{"key":"4278_CR329","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/CEJ.0b013e32834ef16f","volume":"21","author":"R Peir\u00f3-Jord\u00e1n","year":"2012","unstructured":"Peir\u00f3-Jord\u00e1n R, Krishna-Subramanian S, Hanski ML, L\u00fcscher-Firzlaff J, Zeitz M, Hanski C (2012) The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression. Eur J Cancer Prev 21:413\u2013422","journal-title":"Eur J Cancer Prev"},{"key":"4278_CR330","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ijc.21365","volume":"118","author":"SA Shah","year":"2006","unstructured":"Shah SA, Volkov Y, Arfin Q, Abdel-Latif MM, Kelleher D (2006) Ursodeoxycholic acid inhibits interleukin beta 1 and deoxycholic acid-induced activation of NF-\u03baB and AP-1 in human colon cancer cells. Int J Cancer 118:532\u2013539","journal-title":"Int J Cancer"},{"key":"4278_CR331","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.bbamcr.2009.05.003","volume":"1793","author":"R Feldman","year":"2009","unstructured":"Feldman R, Martinez JD (2009) Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR. Biochem Biophys Acta 1793:1387\u20131394","journal-title":"Biochem Biophys Acta"},{"key":"4278_CR332","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/jgh.14526","volume":"34","author":"YH Kim","year":"2019","unstructured":"Kim YH, Kim JH, Kim BG, Lee KL, Kim JW, Koh S-J (2019) Tauroursodeoxycholic acid attenuates colitis-associated colon cancer by inhibiting nuclear factor kappaB signaling. J Gastroenterol Hepatol 34:544\u2013551","journal-title":"J Gastroenterol Hepatol"},{"key":"4278_CR333","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1152\/ajpgi.00270.2003","volume":"286","author":"G Alpini","year":"2004","unstructured":"Alpini G, Kanno N, Phinizy JL, Glaser S, Francis H, Taffetani S, LeSage G (2004) Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca 2+-, PKC-, and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol 286:973\u2013982","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR334","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.canlet.2015.10.031","volume":"370","author":"N Alasmael","year":"2016","unstructured":"Alasmael N, Mohan R, Meira LB, Swales KE, Plant NJ (2016) Activation of the Farnesoid X-receptor in breast cancer cell lines results in cytotoxicity but not increased migration potential. Cancer Lett 370:250\u2013259","journal-title":"Cancer Lett"},{"key":"4278_CR335","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jsbmb.2008.01.003","volume":"111","author":"J Sun","year":"2008","unstructured":"Sun J, Mustafi R, Cerda S, Chumsangsri A, Xia YR, Li YC, Bissonnette M (2008) Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells. J Steroid Biochem Mol Biol 111:37\u201340","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4278_CR336","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1073\/pnas.1215060109","volume":"109","author":"SM Vogel","year":"2012","unstructured":"Vogel SM, Bauer MR, Joerger AC, Wilcken R, Brandt T, Veprintsev DB, Rutherford TJ, Fersht AR, Boeckler FM (2012) Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2. Proc Natl Acad Sci USA 109:16906\u201316910","journal-title":"Proc Natl Acad Sci USA"},{"key":"4278_CR337","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/bj3560481","volume":"356","author":"AA Powell","year":"2001","unstructured":"Powell AA, LaRue JM, Batta AK, Martinez JD (2001) Bile acid hydrophobicity is correlated with induction of apoptosis and\/or growth arrest in HCT116 cells. Biochem J 356:481\u2013486","journal-title":"Biochem J"},{"key":"4278_CR338","first-page":"108","volume":"1583","author":"D Qiao","year":"2002","unstructured":"Qiao D, Im E, Qi W, Martinez JD (2002) Activator protein-1 and CCAAT\/enhancer-binding protein mediated GADD153 expression is involved in deoxycholic acid-induced apoptosis. Biochem Biophys Acta 1583:108\u2013116","journal-title":"Biochem Biophys Acta"},{"key":"4278_CR339","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1038\/s41388-020-1349-6","volume":"39","author":"R Lin","year":"2020","unstructured":"Lin R, Zhan M, Yang L, Wang H, Shen H, Huang S, Huang X, Xu S, Zhang Z, Li W, Liu Q, Shi Y, Chen W, Yu J, Wang J (2020) Deoxycholic acid modulates the progression of gallbladder cancer through N(6)-methyladenosine-dependent microRNA maturation. Oncogene 39:4983\u20135000","journal-title":"Oncogene"},{"key":"4278_CR340","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00432-014-1890-1","volume":"141","author":"JS Pyo","year":"2015","unstructured":"Pyo JS, Ko YS, Kang G, Kim DH, Kim WH, Lee BL, Sohn JH (2015) Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas. J Cancer Res Clin Oncol 141:1181\u20131188","journal-title":"J Cancer Res Clin Oncol"},{"key":"4278_CR341","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr2211","volume":"10","author":"K Krishnamurthy","year":"2008","unstructured":"Krishnamurthy K, Wang G, Rokhfeld D, Bieberich E (2008) Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide. Breast Cancer Res 10:1\u201316","journal-title":"Breast Cancer Res"},{"key":"4278_CR342","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1053\/gast.2002.32410","volume":"122","author":"JH Yoon","year":"2002","unstructured":"Yoon JH, Higuchi H, Werneburg NW, Kaufmann SH, Gores GJ (2002) Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 122:985\u2013993","journal-title":"Gastroenterology"},{"key":"4278_CR343","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2009.08.030","volume":"290","author":"MK Baek","year":"2010","unstructured":"Baek MK, Park JS, Park JH, Kim MH, Kim HD, Bae WK, Chung IJ, Shin BA, Jung YD (2010) Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells. Cancer Lett 290:123\u2013128","journal-title":"Cancer Lett"},{"key":"4278_CR344","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1038\/sj.onc.1205729","volume":"21","author":"PR Debruyne","year":"2002","unstructured":"Debruyne PR, Bruyneel EA, Karaguni IM, Li X, Flatau G, Muller O, Zimber A, Gespach C, Mareel MM (2002) Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene 21:6740\u20136750","journal-title":"Oncogene"},{"key":"4278_CR345","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1042\/bj3490189","volume":"349","author":"B Halvorsen","year":"2000","unstructured":"Halvorsen B, Staff AC, Ligaarden S, Prydz K, Kolset SO (2000) Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2. Biochem J 349:189\u2013193","journal-title":"Biochem J"},{"key":"4278_CR346","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1002\/jcb.25955","volume":"118","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Lian S, Ung TT, Xia Y, Han JY, Jung YD (2017) Lithocholic acid stimulates IL-8 expression in human colorectal cancer cells via activation of Erk1\/2 MAPK and suppression of STAT3 activity. J Cell Biochem 118:2958\u20132967","journal-title":"J Cell Biochem"},{"key":"4278_CR347","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"TT Nguyen","year":"2019","unstructured":"Nguyen TT, Ung TT, Li S, Lian S, Xia Y, Park SY, Do Jung Y (2019) Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity. Sci Rep 9:1\u201313","journal-title":"Sci Rep"},{"key":"4278_CR348","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.bcp.2005.07.023","volume":"70","author":"K Cheng","year":"2005","unstructured":"Cheng K, Raufman J-P (2005) Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol 70:1035\u20131047","journal-title":"Biochem Pharmacol"},{"key":"4278_CR349","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/carcin\/bgl139","volume":"28","author":"CM Payne","year":"2007","unstructured":"Payne CM, Weber C, Crowley-Skillicorn C, Dvorak K, Bernstein H, Bernstein C, Holubec H, Dvorakova B, Garewal H (2007) Deoxycholate induces mitochondrial oxidative stress and activates NF-\u03baB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28:215\u2013222","journal-title":"Carcinogenesis"},{"key":"4278_CR350","first-page":"663","volume":"2016","author":"SM Centuori","year":"1861","unstructured":"Centuori SM, Gomes CJ, Trujillo J, Borg J, Brownlee J, Putnam CW, Martinez JD (1861) Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells. Biochem Biophys Acta 2016:663\u2013670","journal-title":"Biochem Biophys Acta"},{"key":"4278_CR351","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbrc.2012.07.137","volume":"425","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Zhu M, Lance P (2012) Stromal COX-2 signaling activated by deoxycholic acid mediates proliferation and invasiveness of colorectal epithelial cancer cells. Biochem Biophys Res Commun 425:607\u2013612","journal-title":"Biochem Biophys Res Commun"},{"key":"4278_CR352","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1091\/mbc.e03-12-0894","volume":"15","author":"R Pai","year":"2004","unstructured":"Pai R, Tarnawski AS, Tran T (2004) Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell 15:2156\u20132163","journal-title":"Mol Biol Cell"},{"key":"4278_CR353","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00432-003-0493-z","volume":"129","author":"Z Li","year":"2003","unstructured":"Li Z, Tanaka M, Kataoka H, Nakamura R, Sanjar R, Shinmura K, Sugimura H (2003) EphA2 Up-regulation induced by deoxycholic acid in human colon carcinoma cells, an involvement of extracellular signal-regulated kinase and p53-independence. J Cancer Res Clin Oncol 129:703\u2013708","journal-title":"J Cancer Res Clin Oncol"},{"key":"4278_CR354","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/00042737-200108000-00012","volume":"13","author":"V Milovic","year":"2001","unstructured":"Milovic V, Teller IC, Murphy GM, Caspary WF, Stein J (2001) Deoxycholic acid stimulates migration in colon cancer cells. Eur J Gastroenterol Hepatol 13:945\u2013949","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4278_CR355","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.0014-2972.2001.00938.x","volume":"32","author":"V Milovic","year":"2002","unstructured":"Milovic V, Teller IC, Faust D, Caspary WF, Stein J (2002) Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur J Clin Invest 32:29\u201334","journal-title":"Eur J Clin Invest"},{"key":"4278_CR356","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/carcin\/22.1.35","volume":"22","author":"D Qiao","year":"2001","unstructured":"Qiao D, Stratagouleas ED, Martinez JD (2001) Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis 22:35\u201341","journal-title":"Carcinogenesis"},{"key":"4278_CR357","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/carcin\/22.6.957","volume":"22","author":"D Qiao","year":"2001","unstructured":"Qiao D, Gaitonde SV, Qi W, Martinez JD (2001) Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation. Carcinogenesis 22:957\u2013964","journal-title":"Carcinogenesis"},{"key":"4278_CR358","first-page":"941","volume":"36","author":"HY Lee","year":"2010","unstructured":"Lee HY, Crawley S, Hokari R, Kwon S, Kim YS (2010) Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR\/PKC\/Ras\/ERK\/CREB, PI3K\/Akt\/IkappaB\/NF-kappaB and p38\/MSK1\/CREB pathways and negative JNK\/c-Jun\/AP-1 pathway. Int J Oncol 36:941\u2013953","journal-title":"Int J Oncol"},{"key":"4278_CR359","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/carcin\/23.8.1281","volume":"23","author":"S Lechner","year":"2002","unstructured":"Lechner S, M\u00fcller-Ladner U, Schlottmann K, Jung B, McClelland M, R\u00fcschoff J, Welsh J, Sch\u00f6lmerich J, Kullmann F (2002) Bile acids mimic oxidative stress induced upregulation of thioredoxin reductase in colon cancer cell lines. Carcinogenesis 23:1281\u20131288","journal-title":"Carcinogenesis"},{"key":"4278_CR360","first-page":"176","volume":"43","author":"DK Lee","year":"2004","unstructured":"Lee DK, Park SY, Baik SK, Kwon SO, Chung JM, Oh E-S, Kim HS (2004) Deoxycholic acid-induced signal transduction in HT-29 cells: role of NF-kappa B and interleukin-8. Korean J Gastroenterol 43:176\u2013185","journal-title":"Korean J Gastroenterol"},{"key":"4278_CR361","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","volume":"176","author":"T Fu","year":"2019","unstructured":"Fu T, Coulter S, Yoshihara E, Oh TG, Fang S, Cayabyab F, Zhu Q, Zhang T, Leblanc M, Liu S, He M, Waizenegger W, Gasser E, Schnabl B, Atkins AR, Yu RT, Knight R, Liddle C, Downes M, Evans RM (2019) FXR regulates intestinal cancer stem cell proliferation. Cell 176:1098-1112.e1018","journal-title":"Cell"},{"key":"4278_CR362","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.4161\/cc.21029","volume":"11","author":"I Casaburi","year":"2012","unstructured":"Casaburi I, Avena P, Lanzino M, Sisci D, Giordano F, Maris P, Catalano S, Morelli C, And\u00f2 S (2012) Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation. Cell Cycle 11:2699\u20132710","journal-title":"Cell Cycle"},{"key":"4278_CR363","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2019.04.009","volume":"454","author":"L Gao","year":"2019","unstructured":"Gao L, Lv G, Li R, Liu WT, Zong C, Ye F, Li XY, Yang X, Jiang JH, Hou XJ, Jing YY, Han ZP, Wei LX (2019) Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK\/mTOR dependent autophagy activation. Cancer Lett 454:215\u2013223","journal-title":"Cancer Lett"},{"key":"4278_CR364","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-44","volume":"10","author":"M Liao","year":"2011","unstructured":"Liao M, Zhao J, Wang T, Duan J, Zhang Y, Deng X (2011) Role of bile salt in regulating Mcl-1 phosphorylation and chemoresistance in hepatocellular carcinoma cells. Mol Cancer 10:1\u20139","journal-title":"Mol Cancer"},{"key":"4278_CR365","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3892\/or.2017.5830","volume":"38","author":"M Zhou","year":"2017","unstructured":"Zhou M, Qi Z, Zhao J, Liao M, Wen S, Manyi Y (2017) Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC. Oncol Rep 38:1742\u20131750","journal-title":"Oncol Rep"},{"key":"4278_CR366","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/ijc.30219","volume":"139","author":"G Xie","year":"2016","unstructured":"Xie G, Wang X, Huang F, Zhao A, Chen W, Yan J, Zhang Y, Lei S, Ge K, Zheng X, Liu J, Su M, Liu P, Jia W (2016) Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. Int J Cancer 139:1764\u20131775","journal-title":"Int J Cancer"},{"key":"4278_CR367","first-page":"12822","volume":"30","author":"Z Shellman","year":"2016","unstructured":"Shellman Z, Aldhahrani A, Verdon B, Mather M, Paleri V, Wilson J, Pearson J, Ward C, Powell J (2016) Bile acids: a potential role in the pathogenesis of pharyngeal malignancy. Clin Otolaryngol 30:12822","journal-title":"Clin Otolaryngol"},{"key":"4278_CR368","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2017.10.017","volume":"412","author":"X Liu","year":"2018","unstructured":"Liu X, Chen B, You W, Xue S, Qin H, Jiang H (2018) The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2\/STAT3 signaling pathway in non-small cell lung cancer. Cancer Lett 412:194\u2013207","journal-title":"Cancer Lett"},{"key":"4278_CR369","doi-asserted-by":"publisher","first-page":"967","DOI":"10.18632\/oncotarget.13514","volume":"8","author":"R Sharma","year":"2017","unstructured":"Sharma R, Quilty F, Gilmer JF, Long A, Byrne AM (2017) Unconjugated secondary bile acids activate the unfolded protein response and induce golgi fragmentation via a src-kinasedependant mechanism. Oncotarget 8:967\u2013978","journal-title":"Oncotarget"},{"key":"4278_CR370","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1158\/0008-5472.CAN-07-5460","volume":"68","author":"CJ Yen","year":"2008","unstructured":"Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, Hung MC (2008) Bile acid exposure up-regulates tuberous sclerosis complex 1\/mammalian target of rapamycin pathway in Barrett\u2019s-associated esophageal adenocarcinoma. Can Res 68:2632\u20132640","journal-title":"Can Res"},{"key":"4278_CR371","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ijc.21917","volume":"119","author":"T Soma","year":"2006","unstructured":"Soma T, Kaganoi J, Kawabe A, Kondo K, Tsunoda S, Imamura M, Shimada Y (2006) Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: a possible mechanism of angiogenesis in patients with esophageal cancer. Int J Cancer 119:771\u2013782","journal-title":"Int J Cancer"},{"key":"4278_CR372","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1111\/jcmm.13271","volume":"21","author":"DO Prichard","year":"2017","unstructured":"Prichard DO, Byrne AM, Murphy JO, Reynolds JV, O\u2019Sullivan J, Feighery R, Doyle B, Eldin OS, Finn SP, Maguire A, Duff D, Kelleher DP, Long A (2017) Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett\u2019s oesophagus by modulating integrin-\u03b1v trafficking. J Cell Mol Med 21:3612\u20133625","journal-title":"J Cell Mol Med"},{"key":"4278_CR373","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.surg.2009.06.050","volume":"146","author":"DJ Morrow","year":"2009","unstructured":"Morrow DJ, Avissar NE, Toia L, Redmond EM, Watson TJ, Jones C, Raymond DP, Litle V, Peters JH (2009) Pathogenesis of Barrett\u2019s esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells. Surgery 146:712\u2013714","journal-title":"Surgery"},{"key":"4278_CR374","first-page":"185","volume":"61","author":"G Burnat","year":"2010","unstructured":"Burnat G, Majka J, Konturek PC (2010) Bile acids are multifunctional modulators of the Barrett\u2019s carcinogenesis. J Physiol Pharmacol 61:185\u2013192","journal-title":"J Physiol Pharmacol"},{"key":"4278_CR375","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10620-013-2877-5","volume":"59","author":"R Zhang","year":"2014","unstructured":"Zhang R, Yin X, Shi H, Wu J, Shakya P, Liu D, Zhang J (2014) Adiponectin modulates DCA-induced inflammation via the ROS\/NF-kappa B signaling pathway in esophageal adenocarcinoma cells. Dig Dis Sci 59:89\u201397","journal-title":"Dig Dis Sci"},{"key":"4278_CR376","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1152\/ajpgi.00340.2011","volume":"302","author":"HB Roesly","year":"2012","unstructured":"Roesly HB, Khan MR, Chen HDR, Hill KA, Narendran N, Watts GS, Chen X, Dvorak K (2012) The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: The role of deoxycholic acid. Am J Physiol Gastrointest Liver Physiol 302:864\u2013872","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR377","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1152\/ajpgi.00092.2011","volume":"301","author":"X Huo","year":"2011","unstructured":"Huo X, Juergens S, Zhang X, Rezaei D, Yu C, Strauch ED, Wang JY, Cheng E, Meyer F, Wang DH, Zhang Q, Spechler SJ, Souza RF (2011) Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-\u03ba{green}b activation in benign barrett\u2019s epithelial cells. Am J Physiol Gastrointest Liver Physiol 301:278\u2013286","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4278_CR378","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/carcin\/bgl147","volume":"28","author":"GJS Jenkins","year":"2007","unstructured":"Jenkins GJS, D\u2019Souza FR, Suzen SH, Eltahir ZS, James SA, Parry JM, Griffiths PA, Baxter JN (2007) Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: The potential role of anti-oxidants in Barrett\u2019s oesophagus. Carcinogenesis 28:136\u2013142","journal-title":"Carcinogenesis"},{"key":"4278_CR379","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/mutage\/gen029","volume":"23","author":"GJS Jenkins","year":"2008","unstructured":"Jenkins GJS, Cronin J, Alhamdani A, Rawat N, D\u2019Souza F, Thomas T, Eltahir Z, Griffiths AP, Baxter JN (2008) The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-\u03baB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis 23:399\u2013405","journal-title":"Mutagenesis"},{"key":"4278_CR380","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/gut.2007.121244","volume":"56","author":"S Song","year":"2007","unstructured":"Song S, Guha S, Liu K, Buttar NS, Bresalier RS (2007) COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett\u2019s oesophagus and oesophageal adenocarcinoma. Gut 56:1512\u20131521","journal-title":"Gut"},{"issue":"2007","key":"4278_CR381","first-page":"540","volume":"142","author":"Y Hu","year":"1960","unstructured":"Hu Y, Jones C, Gellersen O, Williams VA, Watson TJ, Peters JH (1960) Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells. Arch Surg 142(2007):540\u2013545","journal-title":"Arch Surg"},{"key":"4278_CR382","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-8-333","volume":"8","author":"JT Wu","year":"2008","unstructured":"Wu JT, Gong J, Geng J, Song YX (2008) Deoxycholic acid induces the overexpression of intestinal mucin, MUC2, via NF-kB signaling pathway in human esophageal adenocarcinoma cells. BMC Cancer 8:1\u201310","journal-title":"BMC Cancer"},{"key":"4278_CR383","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-9-190","volume":"9","author":"E Looby","year":"2009","unstructured":"Looby E, Abdel-Latif MMM, Athi\u00e9-Morales V, Duggan S, Long A, Kelleher D (2009) Deoxycholate induces COX-2 expression via Erk1\/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer 9:1\u201315","journal-title":"BMC Cancer"},{"key":"4278_CR384","doi-asserted-by":"publisher","first-page":"153303382094530","DOI":"10.1177\/1533033820945302","volume":"19","author":"M Chen","year":"2020","unstructured":"Chen M, Ye A, Wei J, Wang R, Poon K (2020) Deoxycholic acid upregulates the reprogramming factors KFL4 and OCT4 through the IL-6\/STAT3 pathway in esophageal adenocarcinoma cells. Technol Cancer Res Treat 19:1533033820945302","journal-title":"Technol Cancer Res Treat"},{"key":"4278_CR385","doi-asserted-by":"publisher","first-page":"101057","DOI":"10.18632\/oncotarget.22380","volume":"8","author":"Y Xu","year":"2017","unstructured":"Xu Y, Feingold PL, Surman DR, Brown K, Xi S, Davis JL, Hernandez J, Schrump DS, Ripley RT (2017) Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2. Oncotarget 8:101057\u2013101071","journal-title":"Oncotarget"},{"key":"4278_CR386","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.molonc.2016.04.007","volume":"10","author":"S Joshi","year":"2016","unstructured":"Joshi S, Cruz E, Rachagani S, Guha S, Brand RE, Ponnusamy MP, Kumar S, Batra SK (2016) Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. Mol Oncol 10:1063\u20131077","journal-title":"Mol Oncol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04278-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04278-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04278-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T21:38:33Z","timestamp":1700429913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04278-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":386,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["4278"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04278-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,16]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent to participate"}},{"value":"All authors aggreed on the publication of the current version of manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"243"}}